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Structural and Biochemical Investigation of the Molecular Mechanisms of DNA Damage 




Steven M. Shell  
 
 
The genomes of all living cells are under constant attack from both endogenous and exogenous 
agents that damage DNA.  In order to maintain genetic integrity a variety of response pathways 
have evolved to recognize and eliminate DNA damage.  Replication protein A (RPA), the 
eukaryotic single-stranded DNA (ssDNA) binding protein, is a required factor for all major DNA 
metabolisms.  Although much work has been done to elucidate the nature of the interaction 
between RPA and ssDNA currently there is no structural information on how the full-length 
protein binds to ssDNA.  This study presents a novel examination of the full nucleoprotein 
complex formed between RPA and ssDNA.  We identified three previously unknown contacts 
between ssDNA and lysine residues in DNA binding domain C located in the p70 subunit.  This 
represents the first single amino-acid resolution determination of how full-length RPA contacts 
ssDNA.  The Ataxia-Telangiectasia Mutated and RAD3-Related (ATR) mediated DNA damage 
checkpoint and nucleotide excision repair (NER) pathway are primarily responsible for repair of 
UV-C-induced photolesions in DNA.  However, it is unclear how these two pathways are 
coordinated.  We found the ATR-dependent checkpoint induces a rapid nuclear accumulation of 
the required NER factor Xeroderma pigmentosum group A (XPA) in both a dose- and time-
dependent fashion. Also, using surface topology mapping we have defined an -helix motif on 
XPA required for XPA-ATR complex formation necessary for XPA phosphorylation.  In 
addition, we have determined that XPA phosphorylation promotes repair of persistent DNA 
3 
lesions, such as cyclobutane pyrimidine dimers. The basis for initial damage recognition in NER 
is structural distortion of duplex DNA; however, the effects of adduct structure and sequence on 
strand opening and recognition are unclear.  Using the E. coli NER system we determined that 
the identity of the adduct dictates the size of the strand opening generated by the UvrA2B 
complex.  In addition we found that the sequence immediately surrounding the damaged 
nucleotide affects damage recognition by influencing the amount of helical distortion induced by 
the adduct.  These effects are a result of the equilibrium conformation the adduct adopts in 
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DNA Damage Response and Repair 
 The genomes of all living cells are under constant attack from both endogenous and 
exogenous agents that damage DNA.  These agents include metabolic byproducts, radiation, and 
chemicals taken up by the cells from their environment.  Left un-repaired, DNA damage can lead 
to mutation, chromosome rearrangements, and ultimately genome instability and death of the 
organism.  In humans, it is estimated approximately 80%-90% of cancers can be attributed to 
DNA damage (1, 2).  In response to this threat cells have developed biochemical pathways to 
detect and repair DNA damages or to target the cell for apoptosis.  Figure 1-1 illustrates how 
DNA damage elicits a complex cellular response in eukaryotes that coordinates multiple 
pathways to either repair DNA or eliminate heavily damaged cells in an effort to promote 
genome stability. 
 
Figure 1-1.  DNA Damage Response in Eukaryotic Cells (Adapted from Sancar et al. (3)) 
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 DNA damage can be classified according to the type of structural changes they induce in 
DNA.  There are three major classes of DNA damage:  1. damage to the nucleotide base, 2. 
damage to the phosphodiester backbone, and 3. DNA cross-links, which include DNA-protein 
cross-links, interstrand DNA cross-links, and intrastrand DNA cross-links.   The type of DNA 
damage determines which of the DNA repair pathways is required to correct the damage and 
restore the correct DNA structure (3).  My research has focused on the nucleotide excision repair 
(NER) pathway; therefore, this dissertation will primarily address this repair pathway and how 
NER and the DNA damage checkpoint pathways are coordinated during repair. 
 
Nucleotide Excision Repair 
 Nucleotide excision repair (NER) is the primary repair pathway responsible for removing 
a wide variety of structurally unrelated bulky DNA damages including UV-induced pyrimidine 
dimers and chemically adducted nucleotides (1, 3).  In humans, defects in NER lead to the 
clinical disorder Xeroderma pigmentosum (XP), which is characterized by an increased 
sensitivity to ultraviolet light and a predisposition to development of skin cancer (2, 4). The 
nucleotide excision repair pathway is common to both prokaryotes and eukaryotes and occurs via 
a similar general mechanism; however, there does not appear to be any evolutionary link 
between the two systems.  In both prokaryotes and eukaryotes, NER occurs through a five-step 
process: 1. DNA damage recognition, 2. dual incisions flanking the damage site, 3. release of the 
damaged oligonucleotide, 4. DNA synthesis to fill the gap, and 5. ligation of the newly 
synthesized DNA into the helix (1, 3).  The versatility of NER to repair such a wide variety of 
DNA damages is derived from the fact that initial damage recognition is based on sensing 
distortions to the Watson-Crick DNA structure rather than recognition of the adduct itself.  
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Although the general NER mechanism is similar in both prokaryotes and eukaryotes, there are no 
protein or protein complex homologs between the two systems  (reviewed in reference (3)).   
 
Prokaryotic NER 
 In prokaryotes the UvrABC nuclease system plays a major role in nucleotide excision 
repair.  The UvrABC nuclease system is comprised of three distinct proteins that serve to 
recognize DNA damage, unwind the damage site, and perform the dual incisions to remove the 
damaged oligonucleotide.  Figure 1-2 illustrates the basic steps of prokaryotic NER.  DNA 
damage repair begins by homodimerization of UvrA into UvrA2 (5).  UvrA2 forms a complex 
with UvrB (UvrA2B) that recognizes and unwinds the damage in a two-step process requiring 
hydrolysis of ATP.  It is proposed that the UvrA2 component of the UvrA2B complex initially 
recognizes distortion of the Watson-Crick structure of DNA.  Once helical distortion is 
identified, the UvrA2B complex opens the strands at which point UvrB then verifies the presence 
of the adduct (6, 7).  Strand opening is believed to facilitate the formation of a stable UvrB-DNA 
complex as well as the dissociation of UvrA2 from the damage site (8, 9).  Two molecules of 
UvrC are then recruited through direct interaction with UvrB to form the UvrBC2 pre-incision 
complex.  Formation of the UvrBC2-DNA complex is believed to trigger the 3’ and 5’ 
endonuclease activity of UvrBC2, releasing the damaged oligonucleotide and dissociation of 
UvrBC from the site by UrvD (10-12).  DNA polymerase then fills the resulting gap and the 
patch is ligated into the helix (13, 14).  The UvrABC nuclease system represents an efficient 
mechanism for the removal of a large variety of DNA damages and has been well studied as a 





Figure 1-2:  Prokaryotic Nucleotide Excision Repair (Adapted from Van Houten (10)) 
Prokaryotic NER is performed by the UvrABC nuclease system in an ATP-dependent 
mechanism.  The UvrA2B complex senses DNA damage in a two-step model that identifies both 
distortion in the Watson-Crick structure in addition to the adduct and unwinds the damage site.  
Strand opening facilitates dissociation of UvrA2 and formation of a stable UvrB-DNA complex.  
UvrC is then recruited through interaction with UvrB to form the UvrBC2 pre-incision complex 




 Eukaryotic nucleotide excision repair occurs through a similar mechanism as described 
for prokaryotes; however, there are some major differences between the two pathways. 
First, in prokaryotes only three proteins are required for the recognition and incision of the 
damage site whereas eukaryotic NER requires at least 13 factors to efficiently incise DNA 
damage (15-17).  In addition, the UvrABC proteins have no additional function in DNA 
metabolism while many of the factors in eukaryotic NER are required for many other pathways, 
such as DNA replication, recombination, and gene transcription (3).   
Like prokaryotic NER, eukaryotic NER is classified into two categories defined by how 
DNA damage is identified:  1) global genome repair (GGR) and 2) transcription-coupled repair 
(TCR).  GGR removes DNA damage from the entire genome while TCR removes damage from 
actively transcribed regions of the chromatin (reviewed in (3, 18)).  Figure 1-3 outlines the basic 
mechanism of GGR.  Eukaryotic NER occurs via a sequential mechanism in which proteins and 
protein complexes perform the actions of damage recognition, dual incision, and re-synthesis.  
The XPC-HR23B protein complex recognizes and binds to the damage site to initiate DNA 
damage repair.  Although XPC-HR23B is sufficient for damage recognition, the damaged DNA 
binding complex (DDB) and centrin2 protein interact with XPC-HR23B to stimulate damage 
recognition.  Once the damage site is specified, transcription factor IIH (TFIIH), replication 
protein A (RPA), and XPA are recruited to verify the damage site and unwind the DNA in an 
ATP-dependent manner to prepare the site for dual incision.  After the damaged DNA is 
unwound, the nucleases XPG and XPF-ERCC1 are sequentially recruited to the damage site in 
an event that releases the XPC-HR23B complex and initiates the dual incisions.  Upon excision 




Figure 1-3:  Eukaryotic Global Genome Nucleotide Excision Repair (Adapted from Riedl et al. 
(17)) 
Global genome NER occurs through a mechanism similar to that described for the UvrABC 
nuclease system.  Damage recognition, dual incision, excision, and re-synthesis of the damaged 
region are performed by a series of protein complexes in which factors dissociate or are recruited 
depending on the stage of repair. 
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remains bound to assist in the re-synthesis step.  In TCR, damage repair is initiated without 
involvement of XPA-HR23B when RNA polymerase II becomes stalled at a damaged 
nucleotide.  The subsequent TCR process requires all the same proteins with the exception of the 
XPC-HR23B complex as described in GGR (16, 17). 
 
ATR and the DNA Damage Checkpoints 
Eukaryotic cells have developed numerous pathways to identify and repair DNA damage 
in order to prevent mutagenesis.  The DNA damage checkpoints are a series of pathways that 
serve to coordinate DNA damage repair and cell cycle progression in order to maintain genomic 
integrity (3, 19, 20).  The DNA damage checkpoints consist of four major components:  sensors, 
mediators, transducers, and effectors (3).  The pathways are initiated and represented by two 
checkpoint protein kinases:  1) ataxia-telangiectasia mutated (ATM) and 2) ataxia-telangiectasia 
mutated and RAD3-related (ATR).  These two checkpoint kinases belong to the 
phosphatidylinositol-3-kinase-related protein kinase family and serves as a sensor of DNA 
damage (21, 22).  It is currently believed the ATM kinase responds primarily to agents that 
generated double-strand DNA breaks, such as ionizing radiation. The ATR mediated checkpoint 
response is initiated primarily by UV-induced DNA damage and other damages that result in 
replication stress (3, 20, 23-25).  ATR forms a tight complex with its interaction partner ATRIP.  
It is generally accepted that the ATR-dependent checkpoint pathway responds to long stretches 
of single-stranded DNA coated with RPA through interactions between the ATR-interacting 
protein (ATRIP) and RPA (26).  Once DNA damage is identified the heterotrimeric Rad9-Rad1-
Hus1 (9-1-1) complex is recruited in an ATR-independent manner (27, 28).  Once the 9-1-1 
complex is in place, ATR begins phosphorylation of a variety of downstream targets, such as the 
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DNA damage signal-transduction kinase Chk1 and the p53 transcription factor, that serve to 
arrest cell cycle progression and coordinate DNA damage repair (27-34).   
 
Replication Protein A 
 Replication protein A (RPA) is the major eukaryotic single-stranded DNA (ssDNA) 
binding protein.  RPA was initially identified from HeLa cell extracts as a factor required for 
simian virus 40 DNA replication (35, 36).  RPA is an essential factor required for all major DNA 
metabolisms including DNA replication, repair, recombination, and gene transcription and is 
highly conserved among eukaryotes (reviewed in (37)).  RPA is a heterotrimeric protein 
comprised of three subunits, p70, p32, and p14.  Figure 1-4 presents a schematic illustration of 
the domain/motif arrangement of RPA.  RPA consists of a series of DNA-binding domains 
(DBDs) connected by flexible loops.  Each DBD is constructed around a central 
oligonucleotide/oligosaccharide-binding fold (OB-fold) structurally identified as a five-strand -
barrel capped by an -helix (38-41).  Each of the three subunits contributes a C-terminal helix to 
form the trimerization core and the protein exists in globular form in the absence of ssDNA (41). 
 ssDNA binding to RPA occurs through a sequential mechanism with a defined 5’3’ 
polarity.  RPA binds ssDNA in three modes with the final mode occluding a total of 30 
nucleotides.  It was proposed that these binding modes might represent significant changes in the 
protein conformation as the individual DBDs contact the DNA (42, 43).  However, at present 
there is no structural information available for the full-length RPA protein either free or bound to 
ssDNA.  Figure 1-5 is a proposed model to illustrate how RPA transitions through the binding 
modes.  ssDNA binding is initiated by the tandem DBD-AB domain in central region of p70 that 




Figure 1-4:  Structural Arrangement Of RPA Heterotrimer (Adapted from Bochkarev and 
Bochkareva (38)) 
Human RPA protein is comprised of three subunits, p70, p32, and p14, that interact via C-
terminal -helices.  RPA contains six OB-folds arranged into DNA binding domains (DBDs) 
that are connected through flexible unstructured linkers.  The tandem domain DBD-AB on p70 
contains the primary ssDNA binding affinity of RPA.  DBD-C contains a zinc-finger motif that 
serves to stabilize the structure of the domain.  DBD-D is located on p32 and is flanked by the N-
terminal phosphorylation domain and the C-terminal helix-turn-helix motif.  The entire p14 
subunit is comprised of a single DBD.  It is hypothesized that the DBDs located on p14 and the 
N-terminal domain of p70 do not display any DNA binding activity, however the p14 subunit is 
required for stable heterotrimer formation.  Currently there is no structure for full-length RPA 





Figure 1-5:  A Proposed Model For RPA Binding To ssdna (Adapted from Bochkarev and 
Bochkareva (38))  
RPA binds ssDNA through sequential steps that may involve significant changes in the protein 
conformation.  (A) Globular RPA exists in an “open doughnut” conformation prior to binding.  
(B) ssDNA binding is initiated by the tandem DBD-AB domain that binds 8-10 nucleotides (nt).  
(C) Next, an intermediate structure is formed when DBD-C binds occluding 12-23 nt.  (D) The 
stable binding complex is formed when DBD-D on p32 contacts the DNA bringing the total 
occluded nucleotides to 30.  Although the p70 N-terminal domain and p14 subunit contain DBDs 
it is believed that they do not participate in ssDNA binding and their role has not been defined.  
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proposed that these binding modes might represent significant changes in the protein additional 
binding of DBD-C (located in the C-terminal of p70) occluding 12-23 nt total.  Finally 
the stable binding complex occluding 30 nt is formed when DBD-D in the central region of the 
p32 subunit binds the DNA (38, 40, 41).  These three binding modes represent gross changes in 
the conformation of RPA as it contacts the ssDNA.  Initially it was thought the DBDs align in a 
linear relationship to the ssDNA in the final binding structure; however, our recent report 
indicates that the RPA/ssDNA complex forms a bent conformation in order to maintain the 
integrity of the trimerization core (44).   
 
Xeroderma Pigmentosum Group A 
 Xeroderma pigmentosum group A (XPA) is one of eight protein factors found to be 
deficient in XP.  XPA is a 32kDa zinc metalloprotein and DNA-binding protein required for the 
efficient recognition and removal of bulky DNA lesions by the NER pathway (16, 17, 45). 
Indeed, XP patients deficient in XPA protein display the most severe phenotypes observed in this 
disorder (46).  At present the only known function of XPA is in the NER pathway.  XPA was 
first described as a DNA damage recognition factor, although it is now believed that XPA plays 
a role in DNA damage verification following initial recognition by the XPC-HR23B complex, a 
heterotrimer comprised of the Xeroderma pigmentosum group C protein (XPC) and the human 
homolog of yeast Rad23B protein (HR23B).  XPA has been demonstrated to bind to damaged  
 duplex DNA with low affinity and only moderate specificity (46).  However, unlike XPC, XPA 
is indispensable for both the GGR and TCR repair pathways (31-33), and the minor role of XPA 
as a DNA damage verifier in NER appears inconsistent with the indispensable involvement of 
the protein in NER.  (46-48).  A recent in vitro study using recombinant XPA demonstrates XPA 
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binds with high affinity to a non- damaged DNA substrate containing a single-strand/double-
strand DNA junction indicating XPA may have additional functions beyond damage verification 
in the NER process (49). 
In addition to DNA binding, XPA interacts with a variety of proteins required for NER 
(reviewed in (50)).  Figure 1-6 illustrates the regions of XPA required for binding various 




Figure 1-6:  Domain Organization Of XPA (Adapted from Cleaver and States (46)) 
XPA is a 32kDa protein consisting of 273 amino acids.  XPA is a DNA binding protein that 
interacts with multiple proteins, including RPA, TFIIH, and ERCC1.  The shaded regions 
indicate regions of the protein that are required for interactions with the indicated protein/DNA.  
Also illustrated are the putative nuclear localization signal located in the N-terminal of the 
protein and the zinc finger domain located in the DNA binding region. 
 
XPA plays a role in recruiting repair factors to the damage site.  The primary interaction partner 
of XPA is the replication protein A (RPA).  XPA interacts with both the p70 and p32 subunits of 
RPA and these interactions have been shown to slightly increase the affinity of XPA for 
damaged DNA (48, 51).  XPA also interacts with the transcription factor TFIIH and the ERCC1-
XPF nuclease complex.  This series of protein-protein interactions serves to stabilize the 
intermediate repair structure as well as correctly position the XPF-ERCC1 nuclease (16, 17, 52). 
25
Questions to be Answered in these Studies 
 The formation of the RPA-ssDNA complex is of great importance to all major DNA 
metabolisms.  However, knowledge of the structural nature of this complete complex is poorly 
understood.  Although NMR and X-ray crystallography have provided much information about 
the structure of RPA and the initial interaction of RPA with ssDNA, these techniques have been 
limited to studies on individual domains of the protein.  No structures of either full-length native 
RPA or the RPA-ssDNA complex have been obtained due the technical difficulties associated 
with these techniques.  Previous attempts to use limited proteolysis to map the protein-nucleic 
acid interaction have been limited by the detection method used, primarily SDS-PAGE.  In order 
to achieve high-resolution analysis of the complete nucleoprotein complex a mass spectrometric 
approach was applied to the RPA-ssDNA complex.  Using NHS-biotin to specifically modify 
surface lysine residues allows for single amino acid resolution of the physical contacts between 
RPA and ssDNA.  This work has been published in Biochemistry (2005, 44(3): 971-978) and is 
presented here as Chapter 2 (53). 
 Eukaryotic cells have developed multiple pathways to survey the genome and eliminate 
DNA damage.  It is believed that in vivo the ATR/ATM-mediated DNA damage response 
checkpoints and NER pathways may act cooperatively to repair DNA damage although it is 
unclear how they interact.  Our recent study indicates that the checkpoint kinase ATR interacts 
with the NER factor XPA in response to UV-C irradiation in an event that promotes cell 
survival.  We found that in response to UV-C irradiation ATR binds directly to and 
phoshorylates XPA.  In addition, when XPA-deficient cells were complemented with XPA 
protein lacking the phosphorylation site, cell survival following UV-C irradiation was reduced 
compared to cells complemented with wild-type XPA.  We also reported that ATR co-localized 
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with XPA in nuclear foci, generally viewed as markers of active NER, and that inhibiting ATR 
activity resulted in fewer XPA foci in response to UV-C irradiation.  These results suggest that 
ATR may modulate the NER pathway via direct interaction(s) with XPA.  However, 
phosphorylated XPA represents only a small pool of available cellular XPA and may not fully 
account for the cell survival phenotype.  Our hypothesis is that ATR modulates XPA focus 
formation in response to UV-C irradiation through an unknown mechanism, and this event is 
primarily responsible for the cell-survival phenotype associated with the ATR-XPA interaction.  
To investigate this hypothesis, immunofluorescent microscopy and sub-cellular fractionation 
were applied to determine the availability and localization of XPA following UV-C-irradiation.  
This work has been published in Oncogene (2007, 26(5); 757-764) and is presented here as 
Chapter 3 (54). 
 An interaction between the DNA damage checkpoint kinase ATR and the NER factor 
XPA has been established and characterized to promote cell survival following UV-C irradiation.  
In our previous work it was found that ATR directly binds to and phoshorylates XPA in a UV-C-
dependent manner.  ATR also co-localizes with XPA in UV-C-induced nuclear foci and is 
required for efficient focus formation.  In addition, the ATR-mediated DNA damage checkpoint 
directs the nuclear import of XPA in response to UV-C irradiation.  Although a clear interaction 
between these two factors has been established, the structural nature of the interaction is still 
unclear.  In order to identify regions/motifs of XPA involved in ATR-XPA complex formation, 
selective chemical modification of surface residues coupled with mass spectrometric analysis 
was used to map the topology of XPA in the presence of absence of ATR.  In addition, we 
hypothesize the phosphorylation of XPA by ATR promotes cell survival post UV-C irradiation 
by modulating repair of persistent DNA lesions.  In order to test this hypothesis, we assayed 
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removal of cyclobutane pyrimidine dimers (CPDs) in XPA
-/-
 cells complemented with wild type 
and phosphorylation-deficient XPA to assess the role XPA phosphorylation plays on removal of 
persistent DNA lesions.  This manuscript is pending submission for review and is presented here 
as Chapter 4. 
 The UvrABC nuclease system plays a major role in the prokaryotic NER mechanism and 
is widely used as a model for NER activity.  The simplicity and availability of recombinant 
proteins for this system make it an excellent model for investigations into the specific 
mechanism(s) of NER, such as initial DNA damage recognition.  The current model of DNA 
damage recognition in NER is based on sensing distortions in the regular structure of duplex 
DNA rather than identifying the specific damage.  A series of studies using the UvrABC system 
to investigate the NER-carcinogen induced DNA damage interactions and the effects of DNA 
sequence and structure on damage recognition in NER were published over the course of this 
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Human replication protein A (hRPA), a heterotrimeric single-stranded DNA (ssDNA) 
binding protein, is required for many cellular pathways including DNA damage repair, 
recombination, and replication as well as the ATR-mediated DNA damage response. While 
extensive effort has been devoted to understanding the structural relationships between RPA and 
ssDNA, information is currently limited to the RPA domains, the trimerization core, and a partial 
co-crystal structure.  In this work, we employed a mass spectrometric protein footprinting 
method of single amino acid resolution to investigate the interactions of the entire heterotrimeric 
hRPA with ssDNA. In particular, we monitored surface accessibility of RPA lysines with NHS-
biotin modification in the contexts of the free protein and the nucleoprotein complex. Our results 
not only indicated excellent agreement with the available crystal structure data for RPA70 DBD-
AB-ssDNA complex, but also revealed new protein contacts in the nucleoprotein complex. In 
addition to two lysine residues: K263 and K343 of p70, previously identified by co-
crystallography as direct DNA contacts, we observed protection of five additional lysines (K183, 
K259, K489, K577, and K588 of p70) upon ssDNA binding to RPA. Three residues: K489, 
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K577, and K588 are located in ssDNA binding domain C and are likely to establish the direct 
contacts with cognate DNA. In contrast, no ssDNA-contacting lysines were identified in DBD-
D. In addition, two lysines, K183 and K259, are positioned outside the putative ssDNA-binding 
cleft. We propose that the protection of these lysines could result from the RPA inter-domain 
structural reorganization induced by ssDNA binding. 
 
Introduction 
 Replication protein A, the eukaryotic single-stranded DNA (ssDNA) binding (SSB) 
protein, is an essential protein required for DNA replication, repair, and recombination (42, 43, 
55) as well as in ATR-mediated DNA damage response (56, 57). For damage recognition in 
nucleotide excision repair, RPA binds to the ssDNA region of DNA induced by bulky DNA 
adducts (58, 59). Human RPA (hRPA) is a heterotrimeric protein comprised of three subunits, 
p70, p32, and p14 (42, 43, 56, 57, 60).  The ssDNA binding ability of hRPA is derived from its 
four DNA binding domains (DBDs) located in p70 and p32, and mutational and biochemical 
analyses of recombinant RPA has localized the major ssDNA binding affinity to the DBD-A, 
DBD-B, and DBD-C in p70, with the DBD-D of p32 required for higher-order binding modes. 
The p14 subunit is not implicated in ssDNA binding but is required for stable trimer formation 
(43, 61-63).  Each DBD is constructed around a central oligonucleotide/oligosaccharide-binding 
fold (OB-fold) characterized as a five-strand -sheet coiled to form a -barrel capped by an -
helix between the third and fourth strands (38-41).  RPA binding to ssDNA occurs via a 
sequential and hierarchal pathway with a polarity of 5’ to 3’ in three separate modes, resulting in 
a total of 30 nucleotides occluded.  The interaction begins with an initial binding of 8-10 nt by 
DBD-AB located in the central region of p70, followed by an intermediate binding mode of 12-
30
23 nt by DBD-AB plus DBD-C (C-terminal, p70) (see Figure 1-5).  Finally, a stable complex 
occluding 30 nt is formed when DBD-D, located in the central region of p32, engages the nucleic 




) and low 
cooperativity with a preference for pyrimidine-rich sequence and binds dsDNA and RNA with 
much less affinity (43, 62, 67, 68).  RPA also interacts with a variety of nuclear factors, 
including but not limited to DNA polymerase , p53, XPA, XPG, ERCC1/XPF, Rad51, Rad52, 
UNG2, BRCA1, and BRCA2 (43, 51, 69-74). 
 Although much work has been done to resolve the structures of RPA and the 
RPA/ssDNA complex, how the entire protein interacts with ssDNA remains elusive.  This issue 
becomes even more interesting as dramatic global structural changes have been suggested for 
RPA to facilitate ssDNA binding (61, 66, 75).  NMR and X-ray crystallography have yielded 
important advancements in our understanding of RPA/ssDNA interactions. However, these 
techniques have been limited to characterization of the domains and substructures of RPA (40, 
41, 51, 76, 77). This limitation has hampered our ability to understand how the intact RPA 
protein behaves during binding and how conformational shifts occur during binding mode 
transitions.  Recently, a method has been developed by Kvaratskhelia et al. for accurate mapping 
of protein-nucleic acid contacts using mass spectrometry (78, 79). This method is based on the 
principle of protection of lysine residues in the binding sites from chemical modification when 
nucleic acid is present (78).  Although trypsin digestion methods have previously been used to 
investigate RPA/nucleic acid interactions, these were limited by their detection methods, such as 
SDS-PAGE (39, 75).  In contrast, the mass spectrometric approach allows identification of 
specific protein-nucleic acid contacts at single amino acid resolution under physiologically 
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relevant conditions where integrity of the entire nucleoprotein structure is fully preserved (78, 
79). 
 In our present work, we have used the mass spectrometry footprinting technique (31) to 
identify specific lysine residues within the RPA binding clefts involved in ssDNA binding. Using 
the co-crystal structure of DBDs-AB-dC8mer (22) as an internal control, we have identified three 
new ssDNA contact points within DBD-C of RPA70.  These lysines are similar to those found in 
DBD-AB in location, orientation, and solvent accessibility in the unbound state.  Also, we have 
located two possible inter-domain contact points between the N-terminal domain and DBD-A of 
p70 upon ssDNA binding of RPA.   
 
Materials and Methods 
Protein Purification and Substrate Labeling 
Recombinant human RPA was expressed in E. coli BL21(DE3)-RP (Stratagene) cells and 
purified as previously described (80).  Protein concentration was determined by Bradford Assay 
using Bio-Rad Protein Assay Reagent.  Oligonucleotide substrate was radiolabeled with [-
32
P]ATP (>5000mCi/mmol, Amersham) using T4-PNK (New England Biolabs) and 
unincorporated radioactive nucleotides were removed by P6 Spin Column (Bio-Rad). 
Gel Mobility Shift Assays 
Effects of the biotin modification on RPA-ssDNA binding were determined by gel mobility shift 
assays. Typically, the labeled oligonucleotide dT-50mer (MWG Genetic) substrate (20 M) was 
incubated with unmodified RPA (2 M) at a molar ratio of DNA:RPA = 10:1 in binding buffer 
(40 mM HEPES-KOH, pH7.9, 75 mM KCl, 8 mM MgCl2, 1 mM DTT, 4% glycerol) for 30 
minutes at room temperature. The preformed complex was then exposed to modification with 
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increasing concentrations of N-hydroxysuccinimidobiotin (NHS-biotin, Pierce) for another 30 
min. The reactions were quenched by adding lysine in its free amino acid form (10 mM of final 
concentration).  In parallel experiments, RPA was modified first with NHS-biotin and then 
ssDNA was added to the reaction mix. Reactions were immediately loaded onto 3.5% native 
polyacrylamide gels and electrophoresed in TBE buffer at room temperature. 
Biotin Modification and In-Gel Proteolysis 
Purified hRPA was modified with NHS-biotin in the presence and absence of single-stranded 
oligonucleotide dT30mer. Typically, RPA (2 M) was incubated +/- dT30mer (20 M) in the 
binding buffer at room temperature for 30 minutes and then modified by adding NHS-biotin 
(400mM of final concentration) for additional 30 min incubation at room temperature.  
Modifications were quenched by addition of 10 mM lysine, followed by separation of the RPA 
subunits by SDS-PAGE.  The subunits were visualized by Coomassie Blue staining, excised 
from the gel and extensively destained in 50% methanol / 10% acetic acid.  SDS was removed by 
washing the gel pieces with ammonium bicarbonate, dehydrated with 100% acetonitrile, and 
vacuum desiccated.  Samples were digested with 1 mg trypsin (Roche) in 50 mM ammonium 
bicarbonate overnight at room temperature.  The supernatant was then recovered for MS and 
MS/MS analysis. 
Mass Spectrometric Analysis 
MS spectra were obtained using matrix-assisted laser desorption time of flight (MALDI-TOF) 
and quadrupole-time of flight (Q-TOF) techniques.  MALDI-TOF experiments were performed 
using a Kratos Axima-CRF instrument (Kratos Analytical Instruments) with -cyano-4-hydroxy-
cinnamic acid matrix.  MS and MS/MS analyses were performed on a Micromass (Manchester, 
U.K.) Q-TOF-II instrument equipped with an electrospray source and Micromass cap-LC.  
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Peptides were separated with a Waters Symmetry300 5 μm precolumn (Waters, Milford, MA) 
and a Micro-Tech Scientific (Vista, CA) ZC-10-C18SBWX-150 column using two sequential 
gradients of 5%-40% acetonitrile for 35 minutes and 40%-90% acetonitrile for 10 minutes. 
MS/MS sequence data and the MASCOT automated peptide search engine 
(www.matrixscience.com) were used to identify RPA peptide peaks from the NCBInr primary 
sequence database, and matched peaks were then located in the primary MS spectra.  Protection 
events were qualitatively assigned as the appearance of a peak corresponding to a biotin 
modified peptide in the modified protein spectrum and the absence of the modification peak in 
the modified nucleoprotein complex spectrum.  A protection was considered to be significant 
only when the intensity of a modifiable peak was reduced by at least 85% in the nucleoprotein 
complex spectrum. In order to accurately identify protection events, at least two peaks that are 
not affected by procedures and present in all three spectra (unmodified protein, modified protein, 
and modified nucleoprotein complex) were used as control peaks.  These control peaks served to 
standardize the peak intensities in each spectrum for accurate qualitative assignment of 




Effects of NHS-biotin Modification on ssDNA Binding 
The protein footprinting method we employed is based on the modification of solvent 
accessible lysine residues with the primary amine specific reagent NHS-biotin and the 
subsequent protection of the contact lysines from modification by ssDNA binding.  In order to 
properly identify protein-nucleic acid contacts, the modification procedure must be optimized to 
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ensure the efficiency of NHS-biotin modification and that integrity of the RPA-ssDNA complex 
is preserved.  Therefore, we examined the effects of increasing concentrations of NHS-biotin on 
the ssDNA binding activity of RPA by gel mobility shift assays.  Figure 2-1 shows the results of 
NHS-biotin modification of RPA before (Figure 2-1A) or after (Figure 2-1B) the addition of dT-
50mer.  As NHS-biotin was added in increasing concentrations prior to nucleoprotein  
complex formation, nucleic acid binding affinity was reduced until it was completely lost at a 
concentration of 400 M (2-1A, Lane 6).  This is an indication that the lysine residues being 
modified are necessary for the formation of a stable RPA-ssDNA complex.  However, when 
RPA was occupied by ssDNA prior to addition of NHS-biotin (2-1B), subsequent modification 
of the complex with 400 M NHS-biotin (2-1B, Lane 6) did not disrupt ssDNA binding.  This  
 
 
Figure 2-1.  Effects Of NHS-biotin Modification On RPA-ssDNA Binding 
Lane 1, dT-50mer ssDNA in the absence of RPA and biotinylation, lanes 2 - 6:  0, 50, 100, 200, 
400 mM NHS-biotin.  (A) Addition of increasing amounts of NHS-biotin prior to addition of 
ssDNA blocked critical lysine residues for ssDNA interaction and thus abolished binding 
affinity. (B) Addition of ssDNA prior to NHS-biotin, however, shielded critical lysine residues 
from modification and showed little effects of biotin on the formed RPA-ssDNA complex.   
35
indicates that the lysine residues necessary for stable ssDNA binding are now shielded from 
modification in the nucleoprotein complex.  From these experiments, we have determined a 
concentration of 400 M NHS-biotin for efficient modification of the RPA-ssDNA complex 
while preserving the structural integrity of the complex. 
 
MS and MS/MS Analysis of hRPA-ssDNA Complex 
RPA is a heterotrimer with OB-folds located in all three subunits.  In order to analyze 
each subunit individually, unmodified protein, modified protein, and modified protein-ssDNA 
complex were subjected to SDS-PAGE prior to trypsin proteolysis.  SDS-PAGE electrophoresis 
served two purposes; it allowed for the complete separation of the three subunits and rendered 
the protein in a linear, denatured form that equally exposed all possible trypsin proteolytic sites, 
ensuring a complete and reproducible hydrolysis of the protein.  The hRPA lysines modified 
with NHS-biotin were readily detected by MS and MS/MS analysis of trypsin-generated peptide 
fragments. Figure 2-2A shows a representative MALDI-TOF spectrum for NHS-biotin modified 
p70 with mass/charge peaks assigned to proteolysis-generated peptide fragments.  Figures 2-2B 
and 2-2C exhibit Q-TOF analysis of modified fragment 325-335 (K331+Biotin) of p70. Internal 
fragmentation of this parent peak primarily yielded y-ions (Figure 2-2C), providing sequence 
information read from C-terminus to N-terminus.  The mass increment between the y4 and y5 
ions corresponded to the mass of a biotinylated lysine residue while all remaining y-ions 
corresponded with the p70 sequence (Figure 2-2C). 
 Our following efforts were focused to reveal lysines readily biotinylated in free RPA 
protein, but protected from modification in the nucleoprotein complex.  We assigned protection 




Figure 2-2:  Mass Spectrometric Analysis Of Biotinylation Of RPA Protein 
(A) A typical MALDI-TOF spectrum from m/z 800-3000  of tryptic digestion of biotinylated 
RPA70. Monoisotopic resolution for all the peptide peaks was obtained allowing unequivocal 
assignment of singly charged unmodified and biotinylated peptide fragments.  (B) A typical Q-
TOF spectrum of doubly charged biotinylated p70 peptide fragment.  The molecular mass of this 
ion in the form of m/z (mass per charge) corresponds to peptide fragment 325-335+Biotin.  (C) 
MS/MS analysis of the parent ion (m/z = 754.91) shown in (B) confirms that lysine 331 is 
biotinylated.  The ‘y’ ion series were derived from internal fragmentation of the peptide bonds 
providing sequence information read from the C-terminus (left) to the N-terminus (right).  The 
mass increment between y4 and y5 ions corresponds to a biotinylated lysine while the masses of 
the remaining y-ions correspond perfectly to the amino acid sequence of the fragment.  
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 of the modified protein that are absent in both the modified nucleoprotein complex and the 
unmodified protein spectra.  These m/z peaks correspond to the mass of a tryptically digested 
fragment plus the mass of the number of biotin molecules attached to the peptide.  The number 
of biotin molecules attached to any tryptic peptide is equal to the number of missed lysine 
cleavage sites within the fragment.  Figure 2-3 illustrates a typical assignment of lysine 
protection by Q-TOF analysis.  When native RPA is biotinylated, a peak corresponding to p70  
peptide fragment 260-267 (K263+biotin) is observed. However, when RPA is modified 
following ssDNA binding, this peak is absent, indicating shielding of the lysine in the 
nucleoprotein complex.  Biotin modification of lysine K139 on p32, however, is not protected 
when ssDNA is bound, and the peak corresponding to peptide fragment 139-145 (K139+Biotin) 
persists in both the native and bound RPA spectra.  Peaks C1 and C2 appear as internal control 
peaks to provide reference for peak intensities in each spectrum.    
In our analysis, seven lysine residues in p70 and none from p32 or p14 were found to be 
protected from NHS-biotin modification by ssDNA. Of those, two were previously observed as 
ssDNA contacts by X-ray crystallography (41), three were newly identified to be direct ssDNA 
contact points within DBD-C, and two were located outside of the binding clefts and believed to 
not be associated with ssDNA.  Figure 2-4 illustrates the protection of K588 in DBD-C from 
biotin modification in the presence of dT30mer.  In the absence of ssDNA, K588 is readily 
biotinylated and a peak corresponding to peptide fragment 587-600+Biotin is observed in the 
MALDI-TOF spectrum (Figure 2-4A).  However, when dT30mer is present, K588 is shielded 
from modification by direct contact with the ssDNA and the peak corresponding to the 
biotinylated peptide fragment is significantly diminished (Figure 2-4B).  Also shown in Figure 2-




Figure 2-3:  Identification Of Lysine Residues Protected From Modification By Nucleic Acid 
Binding 
The typical Q-TOF data illustrates the protection of a lysine residue in p70 versus an unprotected 
lysine in p32. The peak corresponding to peptide fragment 260-267+Biotin in p70 is an example 
of protection from modification by binding of ssDNA. When ssDNA is not present, K263 is 
readily modified by NHS-biotin. In the presence of ssDNA, however, the modification peak 
disappears. In contrast, K139 in p32 is a lysine residue not protected by ssDNA binding. A 
modification peak appears upon treatment with NHS-biotin prior to and following addition of 
ssDNA.  Each multiply charged peptide resulted in clearly resolved peak clusters, indicating 
monoisotopic resolution, unmodified peaks C1 and C2 serve as controls. 
 
contact lysine (21). Data for this residue serves as an internal control to confirm the validity of 
our analysis. Figure 2-5 and Table 2-1 summarize the biotin modification data for all three 





Figure 2-4:  MALDI-TOF Analysis Of Protection Of Lysine Residues 
(A) The peptide peak containing modified K343 of DBD-B is absent in the presence of dT30mer 
(B) Similarly, K588 is located in DBD-C and is biotinylated in the absence of ssDNA (A) but is 
protected from modification by direct contact with dT30mer.  (C) The spectra of RPA without 




 Several crystal structures for RPA are currently available including the structure of the 
native form of the tandem DBD-AB (p70183-420) (40), co-crystal structure of DBD-AB with a dC8  
ssDNA (81), structures of N-terminal domain of p70 (82), the C-terminal domain (p32171-270) of 
p32 (51), the native form of the trimerzation core containing DBD-C (p70439-616), DBD-D (p3243-
171), and the entire p14 subunit (41).  The co-crystal structure of DBD-AB with the dC-8mer 
nucleotides provides an excellent internal control for the current analysis of lysine protection 
detected by mass spectrometry.  Figure 2-6A shows the co-crystal structure of DBD-AB with the 
8mer ssDNA (81) with modified lysine residues shown in blue and lysine residues protected 
from modification when dT30mer is present shown in red.  Lysines residues K263 and K343 are 
located in DBD-A and DBD-B, respectively, and are both protected from biotin modification 
when dT30mer is present.  Both residues are oriented pointing into the binding clefts and are 
solvent accessible in the absence of ssDNA as shown by the crystal structure of native protein 
(40).  These lysine residues directly contact ssDNA as it transverses the tandem binding domain.  
The confirmation of the mass spectrometry data with the co-crystal structure of DBD-AB with 
the 8mer ssDNA is an excellent control for supporting that the former method is capable of 
detecting nucleic acid contact points within RPA. 
Based on the available domain structures (40, 41, 75, 81, 82) as reference, our mass 
spectrometry data have shown modifications of about 60% of surface accessible lysines in p70, 
~70% in p32, and ~40% for p14, which include 80% of lysine residues found in the ssDNA 
binding domains. It should be noted that our experiments were performed on full-length hRPA, 
while x-ray structural data are available for the domain or partial hRPA. Therefore, it is possible  
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Figure 2-5:  Summary Of The Footprinting Results In The Context Of The RPA Sequence 
Biotinylation sites in the three subunits of RPA are indicated in the primary amino acid sequence 
either as protected residues (boxed B) or unprotected (un-boxed B).  The locations of domain 
structures are indicated by shading sequence with the name and amino acid numbering of the 
structure. 
 
that a significant number of lysines found to be exposed to solvent in crystallographic studies are 
in fact involved in the inter-domain or inter–motif interactions in the context of full-length form 
of native hRPA. The lysines shielded by protein-protein interactions would not be susceptible to 
NHS-biotin modification. Our results clearly indicate that in addition to K263 and K343, lysine 
residues K489, K577, and K588 located within DBD-C, also are protected in the presence of 
dT30mer. Figure 2-6B shows the crystal structure of DBD-C located in the C-terminal of p70 
(41). The biotin-modified lysine residues are shown in blue while protected lysine residues are 
indicated in red.  Because lysine K489, K577, and K588 are located in the binding cleft of DBD-
C, protection of these residues from biotin-modification strongly suggests that these lysines are 
directly involved in ssDNA interactions.  Although lysine residues K489 and K588 were 
previously implicated as ssDNA contact points by computer assisted molecular modeling (41), 
lysine K577 was not. Similar to K263 and K343 in DBD-AB, the protected residues in DBD-C 
are oriented pointing into the binding cleft and are solvent accessible in the absence of ssDNA. 
The similarities between these protected lysine residues versus those found in DBD-AB such as 
orientation in the binding cleft and solvent accessibility strengthens the claim that these lysine 
residues are ssDNA contact points.       
 Two additional lysine residues, K183 and K259 in DBD-AB, were also protected from 
modification in the presence of dT30mer.  These two residues are not located in either binding 
cleft of DBD-AB nor do they directly contact the 8 nt ssDNA in the co-crystal structure (82). 
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Table 2-1. Proteolysis Fragments Of hRPA Containing Modified Lysines 
 
Fragment Modified K Protection 
RPA70 
82-91 88 - 
158-167 163 - 
164-183 167 - 
168-183 183 + 
202-210 206 - 
217-234 220 - 
235-253 244 - 
254-267 263 + 
260-267 259 + 
314-331 324 - 
325-335 331 - 
340-344 343 + 
489-499 489 + 
500-511 502 - 
576-586 577 + 
587-600 588 + 
589-600 595 - 
RPA32 
38-40 38 - 
82-105 93 - 
128-139 138 - 
139-145 139 - 
RPA14 
31-39 33 - 
40-72 49 - 
 
 
Tryptic digest fragments of hRPA subunits p70, p32, and p14 are shown with the modified lysine 
residue indicated.  Lysines that are shown to be protected from modification in the presence of 
ssDNA are indicated by (+) while residues readily modified in the presence and absence of 





These lysine residues are shown to be oriented toward the N-terminal of the protein and parallel 
to the bound ssDNA, suggesting that these residues may be protected by conformational shift 
within the p70 subunit upon ssDNA binding, in which the N-terminal domain shields K183 and 
K259 from biotin modification.  This inter-domain protein-protein interaction may stabilize the  
  
Figure 2-6: Structural Exhibition Of Modified Lysines In DBD-AB And DBD-C 
(A) Structure of DBD-AB-ssDNA complex (83). Lysine residues in the structures are presented 
as the style of stick. K263 and K343 are found in the binding clefts of DBD-A and DBD-B, 
respectively, and are protected from modification by direct contact with dC8mer.  Lysine 
residues K183 and K259 are not in direct contact with dC8mer, but are protected from 
modification when ssDNA is present. (B) Structure of DBD-C (41). Lysine residues K489, 
K577, and K588 are located in the binding cleft of DBD-C and are protected from biotin 
modification when ssDNA is present, indicating direct contact with ssDNA as it transverses the 
binding cleft.  Biotin-modified lysine residues without protection are shown in blue while the 




protein-ssDNA complex.  As no structure for the N-terminal domain together with DBD-A or 
DBD-AB is available, the exact nature of this protection is unclear, though internal protein-
protein interactions stabilizing the nucleoprotein complex is a possibility. 
Our observation that no protected residues were found in DBD-D (p32) or the OB-fold of 
p14 is consistent with previous biochemical data of the ssDNA binding affinities of these 
domains. Although K139 is located in DBD-D of p32, its orientation positions it out of the 
binding cleft. DBD-D has been implicated in the 30 nt binding mode, though its apparent ssDNA 
affinity is significantly lower than that of DBD-AB or DBD-C on p70 (43, 61-63).  Kim et al. 
(62) reported the Ka for RPA binding to various lengths of oligonucleotides dT and found that 
when the length of ssDNA is increased from 12 nt to 20 nt (the length at which DBD-C engages 
the substrate), the Ka increases >23 fold from 0.16 x 10
9 (resulting from DBD-AB binding) to 3.7 
x 109 M-1. However, the difference between dT20mer and dT30mer (the length at which DBD-D 
engages the substrate) is only ~0.2 fold.  In the present study we monitored only lysine contacts. 
It is possible that other p32 amino acids may contribute to ssDNA binding that could not be 
detected by our approach.  It is currently believed based on biochemical evidence that p14 is not 
involved in ssDNA binding but is required for formation of the stable heterotrimer (38, 41, 43, 
61-63).  Our results reflect this model in that we observed no protection of the two lysine 
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Abstract 
In response to DNA damage, mammalian cells activate various DNA repair pathways to 
remove DNA lesions and, meanwhile, halt cell cycle progression to allow sufficient time for 
repair. NER and the ATR-dependent cell cycle checkpoint activation are two major cellular 
responses to DNA damage induced by UV-C irradiation. However, how these two processes are 
coordinated in the response is poorly understood. Here we showed that the essential NER factor 
XPA underwent nuclear accumulation upon UV-C irradiation, and strikingly, such an event 
occurred in an ATR-dependent manner. Either treatment of cells with ATR kinase inhibitors or 
transfection of cells with siRNA targeting ATR compromised the UV-C-induced XPA nuclear 
translocation. Consistently, the ATR-deficient cells displayed no substantial XPA nuclear 
translocation while the translocation remained intact in ATM -deficient cells in response to UV-
C irradiation.  Moreover, we found that ATR is required for the UV-C-induced nuclear focus 
formation of XPA. Taken together, our results suggested that the ATR checkpoint pathway may 




NER is a major DNA repair mechanism that cells use to remove a large variety of 
structurally unrelated bulky DNA lesions.  In eukaryotic cells the process of NER requires more 
than 25 proteins for DNA damage recognition, incision, excision, and repair re-synthesis to 
restore the original DNA structure (2).  Among the NER proteins, XPA plays a unique role in 
DNA damage recognition as it is required for both GGR and TCR.  XPA is also involved in 
assembly of NER factors at DNA damage site through protein-protein interactions (3, 84).   
 In addition to the repair of DNA damage in response to genotoxic insults, cells also have 
evolved the mechanisms to coordinate repair processes with other cellular pathways.  The DNA 
damage checkpoints are surveillance mechanisms that monitor the integrity of genome and, if 
activated, halt the replication of DNA to allow sufficient time for DNA repair (20).  The 
checkpoint signaling cascades, conceptually, consist of three major biochemical components: 
damage sensors, signal mediators/transducers, and effector molecules.  In mammalian cells, the 
ATR and ATM proteins which belong to the phosphatidylinositol 3-kinase-related kinase (PIKK) 
family, and the Rad9-Rad1-Hus1/Rad17-Rfc2-5 checkpoint complex have been suggested to be 
involved in damage recognition and signaling (28, 85-87).  The ATM kinase seems to be 
activated primarily following generation of double-stranded DNA breaks (DSB), whereas ATR 
kinase is critical for cellular responses to a variety of DNA damage.  When activated, these 
serine/threonine kinases phosphorylate and activate downstream checkpoint factors in DNA 
damage response network and eventually lead to the cell cycle arrest (23-25).  Recent evidence 
has indicated that checkpoint pathways may also modulate DNA repair processes through the 
regulation of phosphorylation and intracellular redistribution of DNA repair proteins (20, 88-91).   
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 While NER and DNA damage checkpoint machineries are able to recognize DNA 
damage independently in vitro, it is believed that both pathways may act in a cooperative manner 
in cells.  However, the cellular relationship between NER and the ATR/ATM-dependent 
checkpoints in DNA damage responses remains elusive.  Several studies have suggested that 
NER may function upstream of cellular checkpoint response to UV-C irradiation as NER 
processing of UV-C damage was necessary for checkpoint activation in non-replicating cells (92-
94).  On the other hand, two checkpoint genes in budding yeast (RAD9 and RAD24, the yeast 
homologues of human BRCA1 and Rad17, respectively) have been shown to be required for the 
induction of NER (95).  In mammalian system, the checkpoint abrogator UCN-01 inhibited the 
NER activity against cisplatin (96).  Given the central role of ATR/ATM kinases in the entire 
DNA damage response network, it is of particular interest to examine whether these kinases 
could directly regulate the cellular NER activity in response to UV-C damage.  Previously, we 
have identified XPA as a phosphorylation substrate for checkpoint kinase ATR in response to 
UV-C irradiation (90, 91).  Here we found that XPA undergoes a dramatic cytoplasm-to-nucleus 
translocation upon treatment of cells with UV-C, and this event also was regulated by ATR.  Our 
results presented herein provide evidence to support the functional link between NER and ATR-
dependent checkpoint pathway and suggest a potential mechanism in which NER and ATR 
checkpoint function cooperatively in cellular responses to UV-C-induced DNA damage. 
 
Materials and Methods 
Cell Culture and Treatments 
Human lung adenocarcinoma cells A549 were obtained from American Type Culture Collection 
and maintained at 37 °C and 5% CO2 in Dulbecco’s Modified Eagles Medium supplemented 
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with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin solution.  Two mutant 
human fibroblast cell lines, ATR (GM18366) and ATM (GM09607), were purchased from 
Coriell Cell Repositories (Camden, NJ).  For UV-C exposure, cells were irradiated with various 
doses of UV-C and further incubated for indicated time at 37 °C before harvesting.   
Sub-cellular Fractionation  
The cellular protein fractionation was performed essentially as described (28, 97).  Briefly, cells 





Triton X-100, 1 mM Na3VO4, 10 mM NaF, –glycerophosphate, 1 
mM PMSF, and protease cocktail [Roche]) on ice for 5 min.  Cytoplasmic proteins were
 
separated from nuclei by low-speed centrifugation (1,300xg for 5 min).  Isolated nuclei were 
washed once with Buffer A and then further lysed in Buffer B (50 mM Tris-HCl, pH 7.8, 420 
mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40 (NP-40), 0.34 M sucrose, 10% glycerol, 1 mM 
Na3VO4, 10 mM NaF, –glycerophosphate, 1 mM PMSF, and protease cocktail) at 4°C for 
30min.  Nuclear proteins were isolated by centrifugation at 14,000xg for 30 min.  Protein 
concentration was determined by Bradford assay (Bio-Rad). 
Western Blotting 
Cell lysates were separated on 8% SDS-polyacrylamide gels and transferred to PVDF 
membrane.  The membranes were blocked with 1x TBST buffer (25mM Tris-HCl, 140mM 
NaCl, 3mM KCl, 0.05% NP-40) containing 5% powered milk and probed using the following 
primary antibodies: anti-XPA, anti-Rad51and anti-Hus1 (Santa Cruz) or anti-ATR and anti-ATM 
(GeneTex, Inc).  The membranes were then incubated with horseradish peroxidase-linked 
secondary antibodies and bound antibodies were visualized using the ECL chemiluminescent 
method (Amersham).   
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Immunofluorescence 
For measurement of nuclear foci formation, cells were grown on 18 mm coverslips overnight 
prior to treatment.  After treatment, cells were extracted with PBS containing 0.5% NP-40, fixed 
with 100% methanol, and blocked in PBS containing 15% FBS.  Primary antibody dilutions used 
are as follows: rabbit anti-XPA (Santa Cruz) 1:500, mouse anti- ATR 1:2000 (GeneTex, Inc).  
Cells were then stained with fluorescence dye-linked secondary antibodies and visualized by 
fluorescent microscopy.  Secondary antibody dilutions are as follows: anti-rabbit Alexa Fluor 
488 1:250 and anti-mouse Alexa Fluor 568 1:250 (Molecular Probes).  Images were captured 
with a Nikon inverted fluorescence microscope with attached CCD camera at 100 X 
magnification and processed using Photoshop 6.0 (Adobe) software.   For nuclear accumulation 
immunofluorescence, cells were grown on 18mm coverslips and transfected with or without 
siRNA as described for 72 hours.  Cells were overlaid with a thin layer of 1xPBS then irradiated 
with 20 J/m
2
 of UV-C and further incubated for 2 hours in standard culture conditions. The cells 
were then washed with PBS, immediately fixed using 100% methanol, and blocked with 15% 
FBS in PBS.   Primary antibody dilutions are as follows:  Mouse-anti-XPA (Kamyia Biomedical) 
1:500, and Rabbit-anti-Calreticulin (Stressgen) 1:1000.   Fluorescent dye-linked secondary 
antibody dilutions are as follows:  Goat-anti-mouse Alexa Fluor 568, 1:250; Donkey-anti-Rabbit 
Alexa Fluor 488, 1:250 (Molecular Probes).   Nuclei were stained using 300 nM DAPI (4',6-
diamidino-2-phenylindole) (Molecular Probes).  Obtained fluorescence microscopic images were 
processed using Photoshop software. 
Small Interfering RNA (siRNA) Transfections 
The siRNA transfection experiments were carried out using TransIT-TKO Transfection Reagent 
(Mirus) by following the manufacturer’s instructions.  Transfection-ready siRNA duplexes were 
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purchased from Dharmacon.  siRNA sequences used in this study were: ATR: 5’-CCU CCG 
UGA UGU UGC UUG A-3’, and SMART pool siRNA for ATM. 
Immunofluorescence DNA Repair Assay 
Cells were grown on 18mm coverslips and transfected with siRNA as described for 72 hours.   
Cells were then irradiated with 20 J/m
2
 of UV-C through a 5 μm polycarbonate isopore filter 
(Millipore) and further incubated for indicated amounts of time.   Cells were then washed with 
PBS and fixed in 2% formaldehyde/0.5% Triton X-100 followed by incubation in 2 M HCl, and 
blocked with 15% FBS in PBS.   Fixed cells were stained with Mouse-anti-[6-4]-photoproduct 
(Clone 64M-2) antibody (MBL) and Goat-anti-Mouse Alexa Fluor 568 fluorescent dye-linked 
secondary antibody (Molecular Probes).   Images were obtained and processed as described 
above.    
 
Results 
UV-C-Induced Nuclear Accumulation of XPA 
 To determine the sub-cellular localization of XPA in cells treated with or without UV-C 
irradiation, A549 cells were irradiated with increasing doses of UV-C, followed by preparation 
of cytoplasmic and nuclear lysates 2 h after treatment (28, 97, 98).  Western blot analysis of the 
samples revealed that the XPA was accumulated in nucleus upon UV-C irradiation in a dose- 
dependent manner up to 20 J/m
2 
(Figure 3-1A, left panel).  The double bands of XPA in SDS-
PAGE at the positions of ~38 and 40 kDa are probably due to the different reduction status of 
XPA related to the formation of disulfide bonds within the protein (99-101).  Consistently, the 
XPA in the cytoplasmic fraction was coincidently reduced, demonstrating that XPA was 




Figure 3-1.  Induction Of XPA Nuclear Accumulation By UV-C Irradiation 
(A) Exponentially growing A549 cells were treated with increasing doses of UV-C followed by a 
2 h recovery.  Proteins from the nuclear extracts, N, and cytoplasmic fractions, C, of the cells 
were separated on SDS-PAGE gels and probed with anti-XPA antibody (left panel).  The UV-C-
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treated whole cells also were analyzed by immunofluorescence microscopy (middle panel).  The 
nuclei were stained with DAPI (4',6-diamidino-2-phenylindole).  Specificity of anti-XPA 
antibody used in these experiments and the total levels of XPA in the whole cell lysates versus 
UV-C doses were demonstrated by Western blotting  (right panel).  Glyceraldehyde-3-phosphate 
dehydrogenase (GADPH) was used as the loading control.  (B) A549 cells were treated with 10 
J/m
2
 UV-C irradiation and then harvested at the indicated time after treatment.  Cytoplasmic and 
nuclear extracts were prepared and probed with anti-XPA antibody (left panel, generated by X. 
Wu).  The UV-C-treated whole cells were also analyzed by immunofluorescence microscopy in a 
time-dependent manner (right panel).   (C) A549 cells were treated with indicated doses of 
camptothecin (CPT) for 2 h, and then washed with PBS and further incubated for another 2 h.  
Cytoplasmic and nuclear extracts were prepared and probed with anti-XPA antibody (generated 
by X. Wu). 
 
redistributed from cytoplasm to nucleus upon UV-C treatment.  In this experiment, both poly 
ADP ribose polymerase (PARP) and -actin were used as nuclear and cytoplasmic proteins, 
respectively, for sub-cellular fractionation and loading controls.  The constant remaining of 
PARP and -actin in nucleus and cytysol, respectively, during cytoplasmic and nuclear extract 
preparations validated our extraction procedures in which no protein leaking between nucleus 
and cytysol occurred.  Furthermore, an increasing accumulation of XPA in nucleus in a dose 
dependent manner was also observed by immunofluorescence analysis of the treated whole cells 
(Figure 3-1A, middle panel).  The anti-XPA antibody used in the present study was highly 
specific as demonstrated by Western blot analysis of whole cell lysates (Figure 3-1A, right 
panel).  Results from this analysis also showed that the total levels of XPA in the cells remain 
essentially unchanged with increasing UV-C doses.  In a time-course experiment, 10 J/m
2
 of UV-
C irradiation resulted in a significant XPA nuclear accumulation in cells about 30 min after the 
exposure, which reached a maximum about 8 h later and decreased to the basal level 24 h after 
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irradiation (Figure 3-1B, and data not shown).  Consistent results also were obtained from the 
immunofluorescence analysis of the cells treated with UV-C (Figure 3-1B, right panel).  Similar 
to the dose-dependent experiments in Figure 3-1A, the total levels of XPA in the cells did not 
change in the time-course experiments either (data not shown).  Interestingly, such nuclear 
translocation of XPA was not observed in cells treated with camptothecin (CPT) (Figure 3-1C), a 
topoisomerase inhibitor that induces double-strand breaks, suggesting that the nuclear 
translocation of XPA is a NER-related or specific event.  It should be mentioned that 5 uM of 
CPT treatment even had significantly higher cytotoxicity than 10 J/m
2
 UV-C irradiation for cells 
with over-expression of XPA protein.  Finally experiments with two other cell lines (HeLa and 
MCF7) exhibited similar UV-C-induced XPA nuclear accumulation (data not shown). 
 
DNA Damage Checkpoints Modulate XPA Nuclear Accumulation 
 Because the checkpoints play an important role in cellular DNA damage responses by 
regulating cell cycle progression, we were particularly interested in determining the relationship 
between the DNA damage checkpoints and NER.  In particular, we wanted to address whether 
ATR/ATM plays a role in governing UV-C-induced XPA nuclear translocation.  For this 
purpose, wortmannin and caffeine, two widely used checkpoint kinase inhibitors, were employed 
in our experiments (102, 103).  Cells were incubated in the presence or absence of wortmannin 
or caffeine after 20 J/m
2
 UV-C exposure.  Efficiency of the ATR-signaling inhibition was 
demonstrated by the loss of UV-C-induced phosphorylation of the downstream signaling effector 
p53 at Ser-15 (Figure 3-2B).  Strikingly, Western blotting of the nuclear extracts did show that 
use of  either agent led to a significant reduction in the UV-C-induced XPA nuclear 
accumulation (Figure 3-2).  By contrast, the nuclear translocation of Hus1, a subunit of Rad9-
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Rad1-Hus1 checkpoint complex that has been suggested to be recruited to chromatin 
independently of ATR (97), remained uncompromised.  Also interestingly, the nuclear 
accumulation of the recombination repair factor Rad51 in response to UV-C was not affected by 
wortmannin or caffeine treatment (Figure 3-2A).  The Hus1 and Rad51 nuclear accumulation 
which appeared to be independent of ATR/ATM was likely due to the cellular response to DSBs 
converted from cyclobutane pyrimidine dimer (CPD) lesions induced by UV-C in a replication-
dependent manner (104), further confirming the specificity of ATR modulation of XPA nuclear 
accumulation.  As reported previously by other laboratories (105, 106), the nuclear levels of 
ATR and ATM remained unchanged after UV-C irradiation and served as the excellent loading 
controls in the present experiment (Figure 3-2A).   
 
ATR is Required for XPA Nuclear Accumulation and Focus Formation 
 To further investigate the role of ATR and ATM in this process, cells were transfected with 
siRNA targeting ATR or ATM prior to UV-C irradiation.  As shown in Figures 3-3A and 3-3B, 
UV-C-induced XPA nuclear accumulation was abolished following transfection with ATR 
siRNA, while the accumulation was only slightly affected by ATM siRNA transfection.  
Transfection with either ATR or ATM siRNA generated little effects on UV-C-induced Hus1 
and Rad51 nuclear translocation (Figure 3-3A), again indicating that the ATR regulation of XPA 
redistribution upon UV-C exposure was a specific cellular event.  The critical role of ATR in the 
UV-C-induced XPA nuclear accumulation was further confirmed in similar experiments with 
ATR- and ATM-deficient cells (Figures 3-4A and 3-4B).  These observations also were 
supported by our immunofluorescence microscopic determination.  As shown in Figure 3-3C, 







Figure 3-2:  UV-C-Induced XPA Nuclear Import Is Wortmannin And Caffeine Sensitive 
(A) A549 cells were mocked treated or treated with 20 J/m
2
 UV-C irradiation, and then 
incubated for 4 h in the presence of 100 μM wortmannin (Wort) (lanes 5 and 6) or 10 mM 
caffeine (Caff) (lanes 3 and 4) before harvesting.  Nuclear extracts were analyzed by Western 
blotting probed with anti-XPA, anti-ATR and anti-ATM, respectively.  Asterisk represents the 
phosphorylated form of XPA, which is also wortmannin and caffeine sensitive (91) (generated 
by X. Wu).  (B) The UV-C-induced XPA nuclear accumulation was quantified using 
densitometry.  (C) The values (the mean ± SD of three independent experiments) were 
normalized to that for mock treated cells (as the value of 1).   
 
in the UV-C-treated cells was largely translocated into nucleus (subpanels d-f).  However, in the 
presence of ATR siRNA in cells, XPA failed to be re-distributed to the nucleus following UV-C 
irradiation (subpanel i), although cells transfected with GFP siRNA had no effect on XPA 
nuclear accumulation  (subpanel l).  Calreticulin (CAL) is an ER-lumen protein and was used as 
a cytosol protein control.  The nuclei were stained with DAPI (4',6-diamidino-2-phenylindole).  
These results indicated that the UV-C-induced re-distribution of XPA to the nucleus was ATR 
kinase-dependent and the lack of re-distribution of XPA in ATR-siRNA transfected cells was not 
an artifact of transfection.  To confirm that the XPA-required NER is impaired in the cells with 
ATR knocked down, we performed the immunofluorescence-based DNA repair assay by 
measuring the removal of UV-C-induced (6-4) photoproducts (6-4PPs) in cells transfected with 
ATR-specific siRNA in a time-course dependent manner (Figure 3-3D).  The UV-C was 
irradiated through a filter containing 5 μm pores overlaid on the cells.  Consistently, the DNA 
lesions in ATR-knocked down cells were significantly more persistent than those in the control 
cells (transfected with GFP siRNA).  We also examined the dependence of XPA nuclear focus 
formation on ATR using the method of immunofluorescence.  Exposure of GFP siRNA-
transfected cell cultures to UV-C resulted in more than 85% of cells exhibiting ATR and XPA 
58
 
Figure 3-3.  ATR is required for XPA nuclear accumulation following UV-C irradiation 
(A) A549 cells were transfected with indicated siRNA, and then treated with 20 J/m
2 
UV-C 72 h 
after transfection.  Nuclear extracts were isolated 4 h after UV-C treatment and immunoblotted 
with the antibodies indicated to the right of each panel.  Asterisk represents the phosphorylated 




































treatment were estimated using densitometry and normalized to those obtained from mock 
treated cells, which were designated as 1.0 (generated by X. Wu).   (C) A549 cells were 
transfected with siRNA targeting either ATR or GFP, or mock-transfected and then irradiated 
with 20 J/m
2
 UV-C 72 hours after transfection.   Cells were then fixed and stained with 
antibodies for either XPA (red) or CAL (green), an ER-lumen protein; nuclei were stained with 
DAPI.  Subpanels c and f illustrate the cellular distribution of XPA in normal (mock-transfected) 
cells with XPA located primarily in the cytosol prior to UV-C irradiation (subpanel c) and 
accumulating in the nuclei following irradiation (subpanel f).   Cells transfected with siRNA for 
ATR did not show similar translocation of XPA to the nucleus following UV-C irradiation 
(subpanel i).  However, cells transfected with GFP siRNA had no effect on XPA nuclear 
accumulation (subpanel l).  (D) Removal of UV-C-induced (6-4)PPs over time were assayed in 
the cells transfected with siRNAs for ATR and GFP, respectively, as analyzed by 
immunofluorescence with anti-(6-4)PPs antibody.  UV-C was irradiated through a filter 
containing 5 μm pores overlaid on the cells.  The foci represent the (6-4)PPs lesions. 
 
foci (Figure 3-5).  XPA foci have been previously shown to colocalized with UV-C-induced 
photolesions (107, 108).  As predicted, siRNA-mediated repression of ATR expression led to a 
reduction of ATR nuclear foci in UV-C-treated cells to levels comparable to untreated controls 
(Figure 3-5).  Strikingly, however, knockdown of ATR resulted in a corresponding decrease in 
XPA foci induced by UV-C treatment (Figure 3-5).  These results, in combination with the above 
data (Figures 3-3 and 3-4), suggest that ATR may exert effects on NER pathway through 




 NER and DNA damage checkpoints are two major pathways in cellular DNA damage 
responses.  However, how these two processes are coordinated in cells in response to DNA 
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damage remains unclear.  Although it was previously reported that the cellular expression level 
of XPC was regulated by p53 (109, 110), a downstream effector in G1/S checkpoint (3), XPC is 
a NER factor only for GGR subpathway.  Importantly, intra-S phase checkpoint lockout of ATR 
kinase activity (kinase-dead) in cells did not result in blocking the response of p53 to DNA 
damage (111).  In this study, we presented evidence that ATR actively targeted the XPA, rather 
than XPC (data not shown), for regulation of its nuclear import in response to DNA damage.  
Such regulation appears to be particularly important as the XPA, an indispensable factor in NER 
for both GGR and TCR, has been widely considered to be a representative protein for NER.  
Cells with XPA deficiency are extremely sensitive to killing by UV-C irradiation.  Unlike XPC 
which is a molecular matchmaker, XPA is required for NER from damage recognition through 
the completion of dual incisions (3, 17).  Targeting other NER proteins for general regulation of 
NER by ATR also seems to be unlikely.  Although RPA is a DNA damage recognition protein in 
NER, it is the major ssDNA binding protein in cells and a major player in replication and many 
other DNA metabolic pathways unrelated to DNA damage and repair.  Thus, it is very unlikely 
and there is no evidence that RPA (except for its phosphorylation which is not required for NER) 
is the target for regulation of NER by ATR in response to UV-C damage.  While TFIIH is a 
major component of NER for both GGR and TCR, it is also an essential complex for normal 
transcription which is independent of DNA repair, making it an unlikely target for regulation of 
NER.  In addition, recent evidence indicated that recruitment of XPF/ERCC1 NER nuclease 
depends on XPA (52).  Finally, it was recently reported that XPA becomes a limiting factor for 
NER at < 10% level of XPA in whole cells (112), which is correlated with the level of XPA 
protein in nucleus.  All these suggest a general mechanism in which the NER could be regulated 




Figure 3-4:  UV-C-Induced XPA Nuclear Accumulation Is Defective In ATR Deficient Cells 
(A) A549 cells, ATR- and ATM-deficient cells were treated with indicated doses of UV-C, and 
nuclear extracts were prepared 4 h after treatment for Western blotting with anti-XPA antibody.  
Asterisk represents the phosphorylated form of XPA (90, 91).  (B) The quantitative data of 





Figure 3-5:  ATR Is Required For The UV-C-Induced XPA Foci Formation 
(A) A549 cells were transfected with ATR siRNA or GFP siRNA as described in Materials and 
Methods, and then treated with 20 J/m
2 
UV-C, 72 h after transfection.  Cells were then subjected 
to immunofluorescence assays with anti-XPA and anti-ATR antibodies.  Subpanels B and F 
(green) are anti-XPA stained cells; Subpanels C and G (red) are anti-ATR stained cells.  
Subpanels D and H are the merged images of the anti-XPA and anti-ATR stained cells.  
Subpanels A and E are DAPI-stained nuclei.  (B) The UV-C-induced ATR and XPA nuclear foci 
were scored from a total of at least 100 randomly selected cells in two independent experiments.  
The cells containing more than 10 foci/cell were defined as positively stained cells.  The data 














































support, an increased UV-C-sensitivity was observed in ATR-mutant cells (113, 114), suggesting 
that the NER efficiency is likely reduced in these cells.  This may, at least in part, be attributed to 
the defect in ATR-dependent nuclear translocation of XPA as loss of cell cycle checkpoints 
themselves did not result in decreased cell viability after DNA damage (115, 116).   
 There are two possible scenarios regarding the underlying mechanism by which ATR 
regulates XPA nuclear import.  Phosphorylation of XPA is unlikely to mediate this process as 
these two events did not correlate with each other in the time course experiments (90, 91).  Given 
that ATR interacted significantly more efficiently and co-localized to DNA damage sites with 
XPA in cells upon UV-C irradiation (as the nuclear foci demonstrated) (Figure 5) (91), it is 
possible that formation of the ATR-XPA complex at the damage sites on chromatin may 
significantly reduce the concentration of free XPA in the nucleus.  This may consequently 
disrupt the balanced XPA concentration across the nuclear membrane separating the nucleus 
from the cytoplasm.  It is speculated, therefore, that a significant concentration gradient of XPA 
across the membrane could form, which may serve as a driving force for efficient cellular 
transportation of XPA from cytoplasm to nucleus.   
 Alternatively, ATR may regulate the nuclear translocation of XPA via other proteins.  
Because XPA and RPA form a complex in vitro and ATR kinase activity was found to be 
necessary for efficient intranuclear relocalization of RPA to DNA damage sites (89), raising the 
possibility of RPA involvement in the XPA nuclear localization.  Nevertheless, knockdown of 
RPA in cells by siRNA did not reduce the UV-C-induced XPA nuclear import (data not shown).  
In addition, a recent study reported that XPA and RPA were loaded separately onto DNA lesions 
in vivo (117).  Notably, XPA contains a potential nuclear localization sequence (NLS) of 
residues 30-42 (118).  The localization of XPA from cytoplasm to nucleus is likely mediated by 
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its interactions with nuclear transport proteins via the NLS.  Recently a cytoplasmic GTPase, 
XAB1, was reported to interact with XPA, and deletion of the residues 30-34 of XPA abolished 
this interaction (119).  Evidently, the potential role of this interaction or related XPA-protein 
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DNA is under constant attack by endogenous and exogenous genotoxic agents that 
threaten genomic stability in all living cells.   In response to DNA damage eukaryotic cells 
activate a series of DNA-damage dependent pathways that serve to arrest cell cycle progression 
and remove DNA damage.   Coordination of cell cycle arrest and damage repair is critical for 
maintenance of genomic stability.  However, this process is still poorly understood.   Nucleotide 
excision repair (NER) and the ATR-dependent cell cycle checkpoint are the major pathways 
responsible for repair of UV-C-induced DNA damage.   In this study we show that ATR 
physically interacts with the NER factor XPA.   Using a chemical modification-coupled mass 
spectrometric footprinting method, we show that ATR interacts with a helix-turn-helix (HTH) 
motif in the XPA minimal DNA binding domain where an ATR-phosphorylation site (serine 
196) is located.   XPA-deficient cells complemented with XPA containing a point mutation of 
S196A displayed a reduced repair efficiency of cyclobutane pyrimidine dimmers (CPDs) as 
compared to cells complemented with wild type XPA.   This suggests that the ATR-dependent 
66
phosphorylation of XPA may promote NER repair of persistent DNA damage.  Taken together, 
our results indicate that the ATR-XPA interaction mediated by the HTH motif of XPA plays an 
important role in DNA-damage responses to promote cell survival and genomic stability 
following UV-C irradiation. 
 
Introduction 
The genomes of all living cells are under constant attack from both endogenous and 
exogenous agents that may lead to genome instability.   The nucleotide excision repair pathway 
(NER) is the primary mechanism in cells for the removal of bulky DNA lesions induced by 
exogenous agents such as UV-C radiation and a variety of genotoxic chemicals (3).   In 
eukaryotic cells NER requires more than 25 proteins to perform the DNA damage recognition, 
excision, and DNA synthesis steps necessary to remove the lesion and restore the integrity of 
DNA (16, 17).   Eukaryotic NER can be further classified into two sub-pathways:  1) 
transcription-coupled NER (TCR) and 2) global genome NER (GGR) (2).   In humans, defects in 
NER lead to the clinical disorder Xeroderma pigmentosum (XP) that is characterized by 
increased sensitivity to UV-C light and a predisposition to development of skin cancer (120, 
121). 
Xeroderma pigmentosum group A protein (XPA) is one of eight factors found to be 
deficient in XP (16, 17, 45).   XPA is a 32kDa zinc metalloprotein that is believed to verify the 
damage site following initial recognition by XPC-HR23B (46, 47).   Unlike XPC, which is 
required only for GGR, XPA is an indispensable factor for both the TCR and GGR pathways.   
Recent studies with recombinant XPA protein also demonstrated that XPA has a high affinity for 
non-damaged DNA substrates containing a single-strand DNA/double-strand DNA junction and 
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suggest that the protein may play an important role in stabilizing the structure of the repair 
intermediate during repair (49).  In addition, ssDNA/dsDNA junction binding may serve to dock 
XPA for recruitment of other NER factors (such as XPF-ERCC1) to the damage site through 
protein-protein interactions to facilitate the pre-incision complex formation (16, 17, 48, 50, 122).  
Given its central role in NER, patients with XPA deficiency display the most severe XP 
phenotypes (16, 17).  
The DNA damage checkpoint pathways serve to monitor genomic integrity and to 
coordinate multiple cellular pathways to ensure efficient repair of DNA damage (20). ATM 
(ataxia-telangiectasia mutated)- and ATR (ATM and RAD3-related)-mediated checkpoint 
pathways represent two major DNA damage checkpoints pathways. Both ATM and ATR are 
protein kinases belonging to the phosphoinositide 3-kinase-like kinase (PIKK) family.  These 
pathways are comprised of a series of DNA damage sensors, signal mediators and transducers, as 
well as downstream effector molecules (3, 20, 123).  The ATR-mediated checkpoint pathway 
serves to sense replication stress and responds primarily to DNA damage typically generated by 
UV-C irradiation (3, 26, 33, 124). ATR is targeted to the sites of elongated RPA-coated ssDNA 
generated when DNA replication forks stall due to DNA damage.  This event is dependent on 
interactions between RPA and the ATR interaction protein ATRIP (26).  Upon sensing DNA 
damage ATR initiates a complex signaling cascade via phosphorylation of downstream protein 
substrates, which ultimately leads to cell cycle arrest (32, 33).   
Our previous studies have implied a role for the ATR-mediated checkpoint pathway in 
modulation of the NER repair pathway (54, 91).  In particular, the NER factor XPA has been 
defined as a direct ATR target for phosphorylation and cytosol-to-nucleus redistribution in 
response to UV-C irradiation (91).  XPA
-/-
 cells complemented with recombinant 
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phosphorylation-deficient XPA protein displayed an increased sensitivity to UV-C irradiation 
compared to cells complemented with wild type XPA (91).  In addition, ATR directed the 
nuclear import of XPA in both a dose-dependent and time-dependent manner for regulation of 
NER activity (54).  ATR and XPA also were shown to co-localize in nuclear foci following UV-
C irradiation and inhibiting ATR resulted not only in lower amounts of XPA available in the 
nucleus but also reduced the number of nuclear foci containing XPA (54, 91).   
Our previous studies present compelling evidence of an ATR-XPA protein-protein 
interaction with multiple consequences for DNA damage repair.  Although there is mounting 
evidence ATR and XPA interact in vivo to promote DNA repair, it remains to be elucidated what 
the structural nature of this interaction is.  Currently there is no structural information available 
for the ATR kinase or a model for how it binds to target proteins.  In this study we present a 
structure-based investigation of the ATR-XPA interaction.  Using our mass spectrometry 
footprinting technique coupled with selective chemical modifications, we identified an -helix 
structure in the XPA minimum DNA-binding domain that participates in the XPA-ATR complex 
formation.  In addition, we demonstrate that the ATR-XPA interaction is required for modulation 
of NER repair of persistent DNA damages generated by UV-C irradiation.   
 
Materials and Methods 
Cell Lines and Tissue Culture 
XPA
-/-
 cells (GM04429) were obtained from Coriell Cell Repositories (Camden, NJ) and were 
cultured in D-MEM supplemented with 10% FBS and 1% penicillin-streptomycin.  XPA-
complemented cells were generated by stably transfecting GM04429 cells with pcDNA3.1 
vectors (Invitrogen) containing either wild type or mutated XPA cDNA with indicated point 
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mutations as described previously (91).  U2OS cells stably transfected with the doxycycline-
inducible FLAG-tagged ATR expression construct were a generous gift from Dr. Paul Nghiem 
(University of Washington Medical Center) and were maintained in D-MEM supplemented with 
10% FBS, 1% penicillin-streptomycin, 0.2mg/mL neomycin, and 0.2mg/mL hygromycin.  All 
cell lines were grown at 37
o
C, 5% CO2.  UV-C irradiation was performed using a 254 nm lamp 
at a fluence of 1.3 J/m
2
/sec.  For time course analysis cells were incubate at 37
o
C, 5% CO2 for 
the indicated amounts of time.   
FLAG-ATR Immunoprecipitation and ATR-XPA Complex Formation 
U2OS-[FLAG]ATR cells were grown in 10 cm tissue culture dishes in D-MEM supplemented 
with doxycycline (5μg/mL) overnight.  Cells were harvested by scraping and re-suspended in 
lysis buffer (50mM HEPES-KOH, pH 7.4, 150mM NaCl, 1mM EDTA, 1% Triton X-100, 1x 
protease inhibitor cocktail [Roche]).  Clarified lysates were immunoprecipitated using 
monoclonal mouse-anti-FLAG M2 antibody (Sigma) and captured with Protein-G coated 
Sepharose beads (Amersham).  Beads were then washed with buffer A (50mM HEPES-KOH, 
pH 7.4, 150mM NaCl, 1mM EDTA, 0.05% NP-20) before washing with high salt buffer (50mM 
HEPES-KOH, pH7.4, 1M NaCl, 1mM EDTA, 0.05% NP-40).  Immunoprecipitates were then 
equilibrated in XPA-ATR binding buffer (50mM HEPES-KOH, pH7.4, 150mM NaCl, 1mM 
EDTA, 1mM ATP), purified 6XHis-XPA was added and incubated at room temperature for 30 
minutes.  Unbound XPA was washed away using buffer B (50mM HEPES-KOH, pH7.4, 
150mM NaCl, 1Mm EDTA, 1mM ATP, 0.05% NP-40).  The resulting complex was modified by 
addition of NHS-biotin (1mM final concentration) for 30 minutes and the reaction quenched by 
addition of 10 mM lysine.  The complexes were resolved by SDS-PAGE electrophoresis, 
visualized by Coomassie stain, and the bands excised from the gel.  SDS was removed by 
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washing with ammonium bicarbonate, dehydrated with 100% acetonitrile and vacuum 
desiccated.  Proteins were digested with 1μg trypsin (Roche) overnight at room temperature and 
peptides eluted with 100% acetonitrile for mass spectrometry analysis. 
MALDI-TOF Analysis 
MS spectra were obtained using matrix-assisted laser desorption time-of-flight (MALDI-TOF) 
mass spectrometry using a Kratos Axima-CRF instrument (Kratos Analytical Instruments).  
Samples were ionized with an -cyano-4-hydroxycinnamic acid matrix.  Data were reproducibly 
compiled and analyzed from 4 independent experiment groups.   
Co-immunoprecipitation 
Co-immunoprecipitation experiments were conducted by lysing cells with lysis buffer A and 
adding dilution buffer to reduce the final NaCl concentration to 150mM.  Lysates (1mg total 
protein) were immunoprecipitated using 2μg monoclonal mouse-anti-XPA (Clone 12FA, 
Kamiya Biochemical).  Samples were resolved on a 4-12% gradient SDS-PAGE for Western blot 
analysis.   
Immunofluorescent DNA Repair Assay 
For immunofluorescence microscopy, cells were grown on coverslips and UV-C irradiated 
through 5μm polycarbonate isopore filters (Millipore) and allowed to recover for the indicated 
amounts of time.  Cells were fixed with 100% methanol and treated with 1M HCl to denature the 
DNA.  Cyclobutane pyrimidine dimers (CPD) were detected with monoclonal mouse-anti-CPD 
(TDM-2, MBL) and donkey-anti-mouse Alexa Fluor 568 (Molecular Probes).  Coveslips were 
mounted in ProLong Antifade with DAPI (Molecular Probes) and visualized using 100x 
magnification.  Data was recorded under single-blind conditions in which the individual 
performing the microscopy did not know the identity of the samples.  Repair of CPD damage 
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was quantified as a percentage of DAPI-stained nuclei containing at least one well-defined CPD 
focus by overlaying the anti-CPD and DAPI images.  At least 50 nuclei per time point were 
counted for damage repair quantification.  Samples then were normalized with time point 0 hour 
representing 100% nuclei containing CPD foci.  Images were analyzed using Photoshop CS.   
Slot-blot DNA Damage Repair Assay 
Cells were seeded at 1x10
6
 cells per 10 cm tissue culture dish and allowed to grow for 48 hours 
prior to UV-C irradiation.  Cells were allowed to recover for the indicated amounts of time and 
genomic DNA was purified using the PureLink Genomic DNA Kit (Invitrogen).  Purified DNA 
was quantified by measuring the A260nm and sample were diluted to 0.2 μg/mL in a final volume 
of 200 uL TE buffer (10mM Tris-HCl, pH 8, 1mM EDTA).  Samples were denatured by 
incubating at 90
o
C for 10 minutes then rapidly chilled on ice for 10 minutes before adding an 
equal volume 2M ammonium acetate.  Samples were filter immobilized on a nylon membrane 
(Hybond-N, Amersham) and probed using monoclonal mouse-anti-CPD antibody.   
Computational Modeling 
An initial model of phosphorylated XPA was generated from the PDB coordinates 1d4u (125) 
using the Biopolymer module of Insight II (Accelrys, Inc.: San Diego, CA, USA, 2005).  Native 
and phosphorylated XPA structures were subsequently minimized in Amber 9 (126).  
Electrostatic surfaces were calculated using the APBS plug-in in Pymol (127-129); atomic 







Protein Purification and ATR-XPA Complex Formation 
Our mass spectrometry-based protein footprinting technique relies on the availability of 
purified proteins for in vitro manipulation.  Recombinant XPA containing an N-terminal 6xHis 
tag was purified from baculovirus infected insect cells as described previously (49).  
Recombinant ATR protein containing an N-terminal FLAG tag was purified from U2OS cells 
expressing ATR mRNA under the control of a tetracycline-inducible promoter (131).  In order to 
obtain the highest yield of ATR we first titrated the protein expression with increasing amounts 
of the tetracycline derivative doxycycline (Figure 4-1A). Specifically, [FLAG]-ATR expression 
was induced by doxycycline at concentrations of 1, 2, and 5 μg/mL.  Whole cell lysates were 
obtained 24 hours post induction and aliquoted for immunoprecipitation with monoclonal 
FLAG-M2 antibody.  Samples with and without immunoprecipitation were then resolved on a 
3%-8% gradient SDS gel prior to transfer onto PVDF membrane and probing with monoclonal 
antibody against human ATR.  As shown in Figure 4-1A, as doxycycline concentration increased 
the amount of total cellular ATR protein also increased.  Incubation with FLAG-M2 antibody for 
immunoprecipitation resulted in a single band only in the doxcycline-induced cell lysates.  Based 
on these results we chose 5 μg/mL doxycycline to induce [FLAG]-ATR expression in the cells.  
To obtain relatively pure ATR for XPA binding, the immunoprecipitated FLAG-ATR was 
washed with buffer containing high salt concentration to wash away proteins associated with the 
FLAG-ATR. Since ATR forms a tight complex with the protein ATRIP in vivo (31), the 
presence of ATRIP co-immunoprecipitated with ATR was monitored with increasing 
concentration of NaCl to test the efficiency of the high salt wash.  Figure 4-1B illustrates that as 




Figure 4-1:  XPA-ATR Complex Preparation 
(A) U2OS-ATR cells were treated with increasing amounts of doxycycline (0, 1, 2, 5 μg/mL) to 
induce expression of the [FLAG]-ATR construct.  Cell lysates were then aliquoted and a small 
amount mixed with anti-FLAG IgG and immunoprecipitated and analyzed by western blot using 
anti-ATR monoclonal IgG.  Western blot analysis indicates as the concentration of doxycycline 
increases the amount of [FLAG]-ATR expression also increases while IP of the FLAG-tagged 
protein results in a single full-length protein.  (B) [FLAG]-ATR protein was immunoprecipitated 
and washed with increasing concentrations of NaCl solution to remove bound proteins.  ATRIP 
forms a tight complex with ATR and is efficiently removed by washing with 1M NaCl.  (C) 
Recombinant 6XHis-XPA was immobilized on Ni-NTA beads and modified with increasing 
amounts of NHS-biotin (0, 100, 250, 500, 1000μM final concentration) before or after addition 
of [FLAG]-ATR lysates.  XPA modified with 1mM NHS-biotin prior to addition of [FLAG]-
ATR lysate prevents formation of the XPA-ATR complex; however, modification after complex 
formation does not affect the protein-protein interaction.  A non-specific band (NS) was co-
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purified by the Ni-NTA matrix and used as a loading control.  (D) [FLAG]-ATR was purified 
from U2OS cells by immunoprecipitation with mous-anti-FLAG M2 antibody and mixed with 
purified recombinant XPA protein before modification with NHS-biotin.  Lane 1:  [6xHis]-XPA 
(unmodified), Lane 2:  [6xHis]-XPA (biotin-modified), Lane 3:  [FLAG]-ATR/[6xHis]-XPA 
complex (unmodified), Lane 4: [FLAG]-ATR/[6xHis]-XPA complex (biotin-modified), Lane 5: 
Immunoprecipitate from un-induced U2OS lysate + [6xHis]-XPA (biotin-modified).  The XPA 
bands were excised from the gel, subjected to in-gel trypsin proteolysis, and the resulting 
fragments analyzed by  MALDI-TOF mass spectrometry.   
 
FLAG-ATR decreased significantly as detected by Western blotting.  Although residual ATRIP 
remained following 1 M NaCl wash, the reduction of tightly-bound ATRIP shows the efficiency 
of the wash procedure. We also found that further increasing the salt concentration above 1 M 
interfered with the antibody-antigen interaction. It also should be noted that since ATR was 
overexpressed in the cells, the majority of the protein may not have complexed with ATRIP in 
vivo. 
 
Chemical Modification of XPA and XPA-ATR Complex 
The high salt-washed FLAG-ATR was then supplied with purified recombinant XPA and 
incubated in binding buffer. Our previous study demonstrated that ATR can directly interact with 
XPA without the presence of a mediating protein factor (91). To map the XPA sites involved in 
the interaction with ATR, a method of chemical modification-coupled mass spectrometry 
footprinting was used to probe the surface topology of proteins (53, 132). The strategy of this 
assay is to chemically modify the surface residues of a protein and the protein in complex with 
another protein, followed by mass spectrometric analysis for determination of their surface 
topology. Comparison of surface topologies of the free and complex forms of the protein allows 
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identification of regions/motifs of the protein involved in the protein-protein interaction.  We 
chose to the probe surface topology of the ATR-XPA complex by modifying the proteins with 
NHS-biotin, a chemical that specifically modifies surface lysine residues.  Success of this 
footprinting assay is based on the ability to modify the protein in complex without disruption of 
the complex, and, therefore, we optimized the concentrations of NHS-biotin used to modify the 
proteins.  We immobilized recombinant [6xHis]-XPA on Ni-NTA beads and modified the 
protein with increasing amounts of NHS-biotin before or after the addition of doxycycline-
induced U2OS whole cell lysates to assay the effects of biotinylation on XPA-ATR complex 
formation.  Figure 4-1C shows that biotinylation of XPA prior to addition of U2OS lysate 
prevents the binding of [FLAG]-ATR to XPA at concentrations greater than 1 mg/mL NHS-
biotin.  However, addition of NHS-biotin following complex formation had no effect on the 
XPA-ATR complex.  The data suggest there could be lysine residue(s) located in or near the 
ATR binding surface of XPA that are surface accessible in the absence of ATR.  A nonspecific 
(NS) protein was observed even when no XPA was added to the beads, indicating that the 
protein was interacting with the nickel matrix and not with either protein (data not shown).  Due 
to the nonspecific nature of the interaction of this protein with the matrix the corresponding band 
was used as a loading control in the analysis (Figure 4-1C). Our observation taken together with 
the fact of no detectable loss of XPA-ATR complex following biotinylation at given 
concentrations indicates that NHS-biotin should be a proper chemical modifier for use to 





MALDI-TOF Analysis of Biotinylated XPA-ATR Complex 
Purified [6xHis]-XPA was added in excess to [FLAG]-ATR immobilized on Protein-G 
beads in normal binding buffer.  As a control XPA was added to immunoprecipitates from un-
induced U2OS cells under the same experimental conditions.  Unbound XPA then was washed 
away, and the resulting samples were biotinylated. In addition, free XPA was also treated under 
the same conditions for biotinylation.   Samples were resolved by 4%-12% gradient SDS-PAGE 
which separated the proteins from one another for individual analysis using mass spectrometry in 
addition to rendering the proteins in a linear, denatured state for full hydrolysis of the protein by 
trypsin protease.  Figure 4-1D (page 75) shows a Coomassie Blue-stained gel prior to excision of 
the protein bands for trypsin digestion. In the absence of ATR, the Coomassie staining reveals 
bands corresponding to XPA in both the unmodified (Lane 1) and modified (Lane 2) forms.  
Four major bands are observed in both the unmodified (Lane 3) and biotinylated (Lane 4) XPA-
ATR complex samples corresponding to ATR, XPA, and the heavy and light chains of the FLAG 
antibody, respectively.  The XPA bands were excised from the gel and subjected to in-gel trypsin 
proteolysis and the resulting peptides were then eluted for MALDI-TOF analysis.   
Figure 4-2 presents a representative mass spectrum for tryptic fragments generated from 
biotin-modified XPA protein.  Monoisotopic resolution was obtained allowing for unequivocal 
assignment of m/z peaks to the XPA primary amino acid sequence.  In addition, biotin-modified 
lysine residues were readily identified by MALDI-TOF analysis based on the appearance of m/z 
peaks absent in the unmodified XPA spectrum and their mass corresponding to a tryptic peptide 
plus the number of biotin molecules attached to the fragment.  The number of biotin molecules 
attached to the peptide is equal to the number of missed lysine cleavage sites contained in the 
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fragment.  Figure 4-3 illustrates the peptide fragments (shaded sequences) and biotinylated 
lysines identified by MALDI-TOF analysis.  
In order to determine which lysine residue(s) were located in the ATR binding surface on 
XPA, we compared the biotinylated peptides derived from XPA modified in complex with ATR 




Figure 4-2  MALDI-TOF Analysis of Biotin-Modified XPA 
A typical MALDI-TOF mass spectrum of peptide fragments resulting from trypsin digestion of 
biotin-modified XPA.  Monoisotopic resolution was obtained for all peptide peaks allowing for 
unequivocal assignment of fragment identity of singly-charged modified and unmodified 




Figure 4-3:  Summary Of MALDI-TOF Analysis Of XPA Protein Modification In Context Of 
The Primary Amino Acid Sequence 
The N-terminal 6His tag added for purification of the recombinant protein is shown by underline 
and the initial methionine residue of untagged protein is labeled 1, the 6His tag residue 
numbering begins at -1 and continues backward to the N-terminus.  Shaded areas indicate trypsin 
digested fragments identified by MALDI-TOF analysis.  Each fragment was assigned with at 
least +/- 1 dalton agreement between the predicted and observed m/z.  Lysine residues identified 
as biotin-modified by mass spectrometry are indicated. 
 
the appearance of an m/z peak for a biotin modified peptide in the free XPA protein and the 
absence of the corresponding m/z peak in spectrum obtained from XPA bound to ATR prior to 
modification.  Figure 4-4 illustrates MALDI-TOF analysis of lysine protection in XPA 
biotinylated in the presence or absence of ATR.  In Figure 4-4A, an m/z peak corresponding to 
biotinylated XPA fragment 184-189 (K188+biotin) appears in the spectrum for modified free  
XPA protein. However, this m/z peak is absent in the spectrum derived from the biotinylated 
XPA-ATR complex sample.  The disappearance of the m/z peak indicates that this lysine residue 
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likely is not exposed to the solvent for biotinylation when XPA is bound by ATR.  In contrast, 
Figure 4-4B illustrates an m/z peak corresponding to biotinylated XPA fragment 31-32 
(K31+biotin) present in both spectra indicating K31 remains solvent-accessible even in the 
presence of ATR.  Peaks C1, C2, and C3 are indicators to provide reference for peak intensity in 
each spectrum.  The data generated by our MALDI-TOF analysis of XPA lysine modification in 
the presence and absence of ATR are summarized in Table 4-1.  
 
Table 4-1. Summary Of MALDI-TOF Analysis Of Biotinylated XPA Peptides   
 
Fragment Modified K Protection 
(-18)-(-5)* -12* - 
31-32 31 - 
87-110 89 - 
136-141 137 - 
151-158 157 - 
164-168 167 - 
184-189 188 + 
190-207 204 - 
218-221 218 - 
216-221 217, 218 - 
219-224 221, 222 - 
222-227 222, 224 - 
223-227 224 - 
232-237 236 - 
259-273 259 - 
260-273 272 - 
 
Lysine residues protected from modification in the presence of ATR are indicated by (+) while 
residues not protected by ATR are indicated by (-).  The asterisk indicates the biotinylated 




Figure 4-4:  MALDI-TOF Analysis Of Lysine Protection In XPA-ATR Complex 
(A) XPA lysine residue K188 is available for modification in the native protein.  However, when 
XPA is in complex with ATR K188 is protected from modification.  Protection from 
modification indicates K188 is located in or near the ATR binding surface on XPA.  (B) Unlike 
K188, lysine residue K31 is modified in both native XPA and XPA in complex with ATR.  The 
lack of protection for this residue indicates it is not located near the binding surface as it is 
surface exposed in the complex.  Peaks C1, C2, and C3 are shown as intensity controls.  
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 K188 and the XPA-ATR Interaction 
We identified 16 lysine residues biotinylated in XPA, of which one residue, K188, was 
protected from modification in the presence of ATR (Table 4-1).  Figure 4-5A is a view of the 
minimum DNA-binding domain structure of XPA as determined by NMR spectroscopy (PBD-
ID 1D4U) (125).  ATR phoshorylates XPA at serine 196 (shown in green), which is located in 
the turn of a helix-turn-helix motif that is part of the proposed DNA-binding cleft.  Protected 
lysine residue K188 (shown in blue) also happens to be located in the helix-turn-helix motif and 
is oriented in nearly the same plane as S196.  This is consistent with the fact that the 
phosphorylation requires the binding of ATR to the XPA.  
Given that K188 is shielded from the solvent in the presence of ATR, site-directed 
mutagenesis of K188 was performed to investigate its possible role in XPA-ATR complex 
formation.  Thus, pcDNA3.1 expression constructs were generated in which lysine residue K188 
was changed to either alanine (K188A) or glutamic acid (K188E) and the vectors were stably 
expressed in XPA
-/-
 cells.  Then co-immunoprecipitation assays were performed to examine the 
effects of the K188 mutations on ATR binding to XPA. As shown in Figure 4-5B, ATR was 
efficiently co-immunoprecipitated from whole cell lysates generated from XPA
-/-
 cells 
complemented with wild type XPA protein by anti-XPA antibody.  Consistent with previous 
observations, UV-C irradiation increased the affinity of ATR for XPA but was unnecessary for 
the interaction (91).  Interestingly, XPA-K188E protein also was able to co-immunoprecipitate 
ATR in a similar pattern to that observed for the wild type protein, although its affinity seemed 
slightly reduced.  Mutating lysine residue K188 to alanine, however, completely abolished the 




Figure 4-5:  Analysis Of K188 Involvement In XPA-ATR Complex Formation 
(A) Ribbon diagram of XPA minimum DNA-binding domain (PDB ID 1D4U, (125)).  Lysine 
residue K188 (shown in blue) is located in the helix-turn-helix motif containing ATR 
phosphorylation site Serine 196.  The close proximity of K188 to S196 supports the modification 
protection data indicating K188 is located in or near the ATR binding surface on XPA.  (B) Point 
mutations were generated in the pcDNA-XPA expression construct generating alanine (K188A) 
and glutamic acid (K188E) substitutions.  The mutated constructs as well as wild type XPA then 
were stably expressed in XPA
-/-
 cells and their effects on the XPA-ATR interaction investigated 
by immunoprecipitation.  The K188A mutant protein was unable to co-immunoprecipitate ATR 
from lysates generated from UV-C irradiated or un-irradiated cells.  The K188E mutant, 
unexpectedly, maintained the interaction between XPA and ATR and exhibited a similar UV-C-
induced pattern as seen for XPA-WT.   
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XPA Phosphorylation and DNA Damage Repair 
A possible role of ATR binding to XPA in cells is to phosphorylate this NER protein. 
The ATR-dependent phosphorylation of XPA has been shown previously to play a role in cell 
survival following UV-C irradiation (54, 91).  Given XPA’s unique role in NER, we 
hypothesized that XPA phosphorylation may play a role in promoting removal of UV-C  
photoproducts. Previous experiments in which ATR kinase activity was inhibited by either 
siRNA knockdown or chemical inhibition reduced the repair rate of (6-4) photoproducts [(6-
4)PP]; however, the lesions were still removed within four hours post irradiation (54).  Repair of 
(6-4)PP still occurs at earlier time points than those associated with XPA phosphorylation, 
indicating the phosphorylation state of XPA may play a role in promoting the removal of 
persistent lesions such as cyclobutane pyrimidine dimers (CPDs).   
To test the notion, we complemented XPA
-/-
 cells with pcDNA3.1 vectors expressing 
either wild type XPA or XPA in which serine 196 was replaced by alanine (S196A).  Cells were 
cultured on glass coverslips and irradiated with UV-C (40 J/m
2
) through 5 μm isopore filters to 
generate localized DNA damage.  Cells then were allowed to recover for various amounts of 
time prior to detection of (CPDs) by immunofluorescent microscopy.  As shown in Figure 4-6A, 
CPD foci (stained in red) formed in the nuclei from cells complemented with wild type XPA 
protein at 0 hours post irradiation. However, the foci decrease in size and frequency as the 
recovery time increases up to 24 hours.  By contrast, nuclei from XPA-S916A-complemented 
cells demonstrate a longer persistence of CPD foci and the damage is repaired at a slower rate 
than observed for cells complemented with wild type XPA protein (Figure 4-5B). Nuclei from 
cells transfected with empty vector alone show no change at all in CPD focus size or frequency 
across time.  
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Figure 4-6:  Effects Of XPA Phosphorylation On Repair Of Cyclobutane Pyrimidine Dimers 
pcDNA constructs containing wild type XPA or XPA-S196A were stably expressed in XPA
-/-
 
cells to assay the effect of XPA phosphorylation on UV-C induced DNA damage repair.  (A) 
Cells were grown on coverslips and UV-C irradiated through 5μm isopore filters to induce 
localized DNA damage.  Cells expressing XPA-S196A phosphorylation-deficient protein 
displayed reduced repair of cyclobutane pyrimidine dimers (CPD) compared to cells expressing 
wild type XPA.  XPA
-/-
 cells containing the empty vector showed no damage repair. (B) Nuclei 
containing CPD foci were counted as a percentage of total DAPI-stained nuclei and plotted 
versus time post-irradiation.  Images were generated in a single-blind method in which the 
individual performing the microscopy did not know the identity of the samples.  At least 50 
nuclei were counted for each time point and CPD-positive nuclei were defined to have at least 
one well-defined focus in a DAPI stained nucleus.  (C) Genomic DNA was isolated from cells 
complemented with wild type or phosphorylation-deficient XPA following UV-C irradiation.  
The DNA was then immobilized on a nylon membrane and total CPDs were detected using 
mouse-anti-CPD antibody.  As in (A), XPA-S196A complemented cells showed reduced repair 
capacity for CPD compared to those complemented with wild type XPA.   
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In a parallel experiment (Figure 4-6C), XPA-complemented cells were irradiated with 
UV-C (20J/m
2
), followed by extraction of the genomic DNA.  Equal amounts of purified DNA 
were then immobilized on a nylon membrane and probed with antibody specific for CPDs.  
Consistent with the results described above, CPD lesions were removed efficiently over a period 
of 24 hours in cells complemented with wild type XPA versus cells transfected with empty 
vector alone.  However, the CPD damages are repaired less efficiently in cells complemented 
with phosphorylation-deficient XPA-S196A protein as illustrated by the persistence of CPDs 
post-irradiation.  These results suggest that XPA phosphorylation promotes the repair of 
persistent UV-C-induced photolesions. 
 
Discussion 
Previous work in our laboratory has demonstrated an interaction between the NER factor 
XPA and the DNA damage checkpoint kinase ATR in response to UV-C irradiation and this 
interaction promotes cell survival. XPA was shown to bind directly to ATR and is 
phosphorylated at serine residue 196 located in the minimum DNA binding-domain of XPA.  In 
addition, ATR directed the UV-C-induced sub-cellular redistribution of XPA from the cytosol to 
the nucleus in both a dose-dependent and time-dependent manner.  Given the central role of XPA 
in nucleotide excision repair, the interaction between XPA and ATR represents a novel 
regulatory pathway for NER by the DNA damage checkpoint. 
In this study a strategy of chemical modification-coupled mass spectrometry protein 
footprinting was applied to studying the structural aspects of the interaction between ATR and 
XPA.  The surface topology of XPA in complex with ATR was probed and identified one lysine 
residue, K188, which is protected from modification in the presence of ATR.  K188 is located in 
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the N-terminal helix of the helix-turn-helix (HTH) motif containing the ATR phosphorylation 
site S196.  In contrast, lysine residue 204 located in the C-terminal helix of the HTH motif is not 
protected from modification by ATR, suggesting that only the N-terminal helix is directly 
involved in the ATR-XPA interaction.  Mutating K188 to alanine effectively abolished the 
interaction between XPA and ATR, while substituting K188 with glutamic acid only moderately 
affected complex formation.  A possible explanation for this observation is that residues other 
than K188 located in the N-terminal -helix mediate the interaction between XPA and ATR; 
however, the presence of the charged residue is required for the stability of the helix motif.  It 
has been described that the stability of an -helix is the result of the electrostatic field generated 
by the residues that make up the motif (133-135).  Indeed, the accumulation of acidic residues 
such as glutamic acid at the N-terminal of an -helix is associated with increased stability of the 
motif (136, 137).  However, Shoemaker et al. describe that the role of side chain charge is a 
function of the ionic strength of the buffer indicating that the presence of charged amino acid 
residues in the N-terminal promotes helix stability compared to uncharged side chains (135).  
The substitution of alanine for lysine may indirectly affect the ATR-XPA complex formation 
through by destabilizing the helical motif required for binding.  Changing K188 to glutamic acid, 
while reversing the charge of the individual residue, may cause redistribution of the charges but 
have limited effect on the global structures of the -helix in the ATR-XPA complex formation.   
In this model, since the individual K188 residue is not a primary participant in the ATR-XPA 
complex, the charge of the residue may not be as important as the presence of the charge to the 
structure of the binding motif.    
Phosphorylation of XPA at serine 196 has been shown previously to moderately promote 
cell survival following UV-C irradiation (91).  Given the only known function for XPA is in 
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NER we assayed the removal of UV-C induced photoproducts to investigate the role of XPA 
phosphorylation in NER.  Cells complemented with XPA-S196A displayed a slower repair rate 
for CPD photoproducts when compared to wild type XPA.  It has been well established that CPD 
is a much more persistent DNA damage than (6-4) photoproducts, both being generated by UV-
C irradiation (138).  Taken together, these results suggest that XPA phosphorylation may play a 
role in stimulating NER activity for removal of persistent DNA damages through an as yet 
undetermined mechanism.  This also appears consistent with our previous observation that 
phosphorylated XPA represents only a small portion of the cellular pool of XPA (91).   
 Phosphorylation of XPA was hypothesized to modulate NER activity by altering the 
affinity of XPA for the damage site.  Indeed, phosphorylated XPA was shown to associate more 
tightly with UV-C-damaged chromatin in cells than the wild-type XPA (91). Previous NMR data 
generated by docking the XPA minimum DNA-binding domain with a ssDNA 9-mer proposed a 
DNA-binding cleft consisting of a series of basic residues aligned across the minimal DNA 
binding domain (125).  Computational modeling of the XPA minimal DNA binding domain was 
performed to predict how phosphorylation of serine 196 affects the surface charge distribution of 
the protein.  Figure 4-7 illustrates that S196 phosphorylation induces an accumulation of 
negative charge along the surface of the helix-turn-helix motif.  However, our computational 
model did not predict any significant change in the positive charge distribution of the DNA-
binding cleft following S196 phosphorylation.  Although we did not observe any change in 
surface charge distribution for the proposed DNA binding cleft, the current structural model of 
the XPA-DNA interaction is based on XPA interacting with a ssDNA substrate.  Our previous 
study indicates that XPA interacts most efficiently with a substrate containing a ssDNA-dsDNA 




Figure 4-7:  Computational Analysis Of XPA Phosphorylation On Surface Charge Distribution 
Phosphorylation of XPA at serine residue 196 by ATR induces an accumulation of negative 
charge along the surface of the helix-turn-helix motif.  Although significant accumulation of 
negative charge was observed, there was no net change in the surface charge distribution of the 
proposed DNA-binding cleft following S196 phosphorylation.  Color code:  Red=negative 
charge, Blue=positive charge, White=neutral charge  (generated by C. A. Brosey) 
 
identified in the NMR study.  The ssDNA-dsDNA substrate is the more-probable structure XPA 
would interact with in vivo based on available complex formation data generated for XPA, RPA, 
TFIIH, and ERCC1 (16, 17).  
Another mechanism for increased chromatin association following S196 phosphorylation 
may be increased affinity of XPA for protein-protein interaction partners.   Our electrostatic 
model clearly indicates that phosphorylation of S196 induces significant accumulation of 
negative charge on the helix-turn-helix motif.  This motif, in addition to DNA binding, is located 
in close proximity to both the RPA70 and TFIIH interaction domains on XPA (46).  Increasing 
the complex formation between RPA70 and/or TFIIH could modulate the association of XPA 
with the DNA damage site independent of the DNA binding affinity.  Also, modifying XPA in a 
manner that is both DNA-damage specific and reversible would provide a mechanism for 
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modulating XPA chromatin association for NER without possibly interfering with additional 




EFFECTS OF DNA ADDUCT STRUCTURE AND SEQUENCE ON DNA DAMAGE 
RECOGNITION BY THE E.COLI NUCLEOTIDE EXCISION REPAIR SYSTEM UV-ABC 
 
Abstract 
In Escherichia coli, the UvrABC nuclease system plays a major role in nucleotide 
excision repair (NER).  The efficiency of damage removal is dependent on the ability of the 
damage repair machinery to recognize the damaged nucleotide and initiate excision repair.  The 
initial damage recognition step is performed by UvrA2 of the UvrA2B heterotrimer complex and 
is dependent on distortion in the Watson-Crick structure of the duplex DNA.  A secondary 
recognition step occurs after a DNA strand opening at the damage site and is carried out by the 
UvrB protein that identifies the specific chemical adduct.  Using synthesized 50bp substrates 
adducted with either 2-aminofluorene (AF) or N-acetyl-2-aminofluorene (AAF), we investigated 
the effects of DNA adduct structure and sequence on the strand opening of repair intermediates 
as well as the efficiency of damage recognition and removal.  The optimum incision for both 
adducts was observed when the damage was contained in a three-nucleotide bubble.  In addition, 
we found that incision efficiency of AF- and AAF- adducted substrates was influenced by the 
DNA sequence surrounding the damaged nucleotide.  In a related study, the sequence 
surrounding an AF-adducted guanidine base influenced the conformation of the aminofluorene 
rings in the duplex structure.  The UvrABC nuclease system was able to remove the AF adduct 




 In Escherichia coli, nucleotide excision repair (NER) is initiated by the UvrABC 
nuclease system.  The UvrABC nuclease system is a well-characterized biochemical pathway 
and represents the paradigm for understanding the mechanism underlying NER in both 
prokaryotic and eukaryotic organisms.  UvrABC initiates NER repair through a sequential action 
that results in dual-incisions flanking the damaged nucleotide followed by DNA synthesis and 
ligation to fill the resulting gap (1, 10, 18).   
E. coli NER is initiated by sensing distortions in the Watson-Crick structure of DNA by 
the UvrA2B heterotrimer complex (Reviewed in Figure 1-2, page 16).  It is proposed that the 
UvrA2 homodimer component is responsible for recognizing distortions in the DNA helix 
induced by the adducted nucleotide.  Once the UvrA2B complex recognizes the helical distortion 
the strands are separated by the ATP-dependent helicase activity of the complex.  At this point 
UvrB performs a secondary recognit,ion step through direct recognition of the specific adduct (5-
7).  Strand opening by the UvrA2B complex is believed to promote the dissociation of UvrA2 
from the damage site and facilitate the formation of a stable UvrB-DNA complex (8, 9).  Two 
molecules of UvrC then are recruited by direct interaction with UvrB to form the UvrBC2-DNA 
pre-incision complex.  Formation of the UvrBC2-DNA complex triggers the endonuclease 
activity of UvrBC2 complex resulting in incision being made 3’ and 5’ to the damaged nucleotide 
and release of the damaged oligonucleotide, and dissociation of UvrBC from the site by UrvD 
(10-12).  DNA polymerase then fills the resulting gap and the patch is ligated into the helix (13, 
14).  The UvrABC nuclease system represents an efficient mechanism for recognition and 
incision of a large variety of DNA damages and has been well studied as a model for nucleotide 
excision repair and its interaction with damaged DNA (10). 
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 Efficient incision of DNA damage by the UvrABC nuclease is dependent on the initial 
DNA damage recognition and strand opening.  Initially, damage is identified by distortions in the 
helix structure of DNA (6, 7).  Recent NMR spectroscopy studies of DNA adducted with either 
2-aminofluorene (AF) or N-acetyl-2-aminofluorene (AAF) indicate each adduct establishes an 
equilibrium between two conformations in duplex DNA.  It has been found that AF adducts 
typically reside in the major groove of duplex DNA, while AAF adducts intercalate into the 
DNA helix between neighboring bases and the conformation equilibrium is sensitive to the 
sequence context surrounding the lesion (139-143).  Adducts that intercalate into the helix have 
been shown to disrupt normal Watson-Crick hydrogen bonding pattern between strands while 
adducts that reside in the major groove tend to preserve the normal bonding pattern (144).  This 
observation suggests that the sequence context may influence the recognition of the damage site 
through influencing the amount of distortion the damage induces.  In addition, strand opening by 
the UvrA2B complex plays a key role in damage recognition and formation of the pre-incision 
complex (7).  Although strand opening is critical for progressive formation of a stable UvrB-
DNA complex and recruitment of UvrC, it is unclear how the identity of the lesion affects this 
step.   Previous studies have indicated that the identity of the adduct may play a role in 
determining the dimension of the pre-incision bubble (7, 145).  However, it is currently unclear 
whether these effects are an indirect result of the helical distortion induced in the duplex or 
directly related to the chemical identity of the adduct itself. 
This chapter summarizes a series of studies performed using the UvrABC nuclease 
system as a model for NER-mediated removal of adducts from duplex DNA.  Using AF- or 
AAF-adducted duplex oligonucleotides in conjunction with in vitro DNA binding and incision 
assays, we investigated the effects of DNA adduct structure and sequence context on the DNA 
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strand opening in E. coli NER.  The UvrA2B complex was found to open an approximately three-
nucleotide bubble containing the adducted nucleotide plus two additional nucleotides 3’ to the 
damage site for recognition of both AF and AAF adducts.  This suggests that the chemical 
identity of the adduct and not the initial helix distortion it induces determines the degree of the 
strand opening in prokaryotic NER.  Also, damages located in A-T rich regions of duplex DNA 
were recognized and incised with higher efficiency than those located in G-C rich regions.  In 
addition, the identity of the nucleotide immediately 3’ to the damaged residue influences the 
amount of helical distortion associated with base stacking of the aromatic rings of AF.  These 
results suggest that the amount of distortion an adduct induces in duplex DNA is dependent on 
both the degree of hydrogen bonding between the strands as well as the position of the adduct in 
the duplex.   
 
Materials and Methods 
DNA Substrate Construction 
Briefly, 30pmol of phosphorylated 11mer (CCATCG
*
CTACC) modified at G
*
 with the C8-
guanine adducts of AF and AAF were ligated with stoichiometric quantities of 5’ 
32
P-labeled 
20mer and phosphorylated 19mer (or none).  Oligonucleotides were annealed in the presence of 
a 28mer bottom strand containing the middle complementary sequence of the top 50mer in 
50mM Tris-HCl, pH7.8, 10mM MgCl2, 10mM DTT, 1mM ATP, and 50mg/mL BSA.  Top 
50mer or 31mer strands were ligated using T4-Ligase at 16
o
C for 12 hours and ligation products 
were purified by gel electrophoresis on a 12% polyacrylamide gel under denaturing conditions.  
Purified 50mer was then annealed to various bottom 50mers while top 31mer was annealed to 
various bottom 50mers + 19mer.  Annealed substrates were then purified on an 8% 
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nondenaturing polyacrylamide gel.  Additionaly, 51 bp DNA substrates containing a single FAF 
or AF adduct with different flanking sequences were constructed by ligating a modified 12-mer 
(CTTCTAG*NCCTC) with a flanking 20-mer (GACTACGTACTGTTACGGCT) and a 19-mer 
(GCAATCAGGCCAGATCTGC) ssDNA oligonucleotides on the 5’- and 3’-sides, respectively. 
The 20-mer was 5’-terminally labeled with 
32
P. The ligation products were purified by urea-
PAGE under denaturing conditions. After purification, the ligated 51-mer was annealed with 
their corresponding complementary strands (bottom 51-mer) and purified again on an 8% 
polyacrylamide native gel for use. 
UvrABC Incision Assays:   
DNA substrates (2nM), labeled at the 5’ termini with 
32
P as described above, were incised by 
UvrABC (UvrA, 15nM; UvrB, 250nM; UvrC, 100nM) or UvrBC (UvrB, 250nM, UvrC, 100nM) 
in UvrABC buffer (50mM Tris-HCl, pH 7.5, 50mM KCl, 10mM MgCl2, 5mM DTT, 1mM ATP) 
at 37
o
C for a specified length of time.  UvrABC enzymes were diluted and premixed prior to 
addition to incision reaction mixes.  Reactions were terminated by adding EDTA (20mM) or 
heating to 90
0
C for 3 minutes. Samples were denatured with formamide buffer and heated to 
90
o
C for 5 minutes, quick chilled on ice for 3 minutes, and digest products were then analyzed 
by gel electrophoresis on a 12% polyacrylamide gel under denaturing conditions.  
32
P labeled 
bands in the gels were visualized and incision products quantified using a Fiji FLA-5000 image 
scanner. 
Quantification of Incision Products 
Quantitative data of radioactivity were obtained using a Fuji FLA-5000 Image Scanner and 
Image Gauge V3.46 software using the volume integration method.  The amount of DNA incised 
(in pmol) by UvrABC was calculated based on the total molar amount of DNA used in each 
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reaction and the percentage of radioactivity in the incision products as compared to the total 
radioactivity.  At least three independent experiments were performed for determination of the 
rates of incision.  The initial rate was determined by a linear least-squares fit of the data collected 
over the incision period. 
UvrA Gel Mobility Shift Assays:   
Substrates (50 bp, 2nM) were incubated with with varying concentrations of UvrA at 37
o
C for 15 
minutes in 20 μL UvrABC buffer (1mM ATP).  After incubation, 2 μL 80% (v/v) glycerol was 
added and the mixture immediately loaded onto a 3.5% native polyacrylamide gel in TBE buffer 
and electrophoresed at room temperature.  Gels were visualized and quantified as described 
above and the Kd was estimated from the UvrA titration concentration at which half the DNA 
substrate had been bound. 
 
Results and Discussion 
Adduct Structure Determines Strand Opening by UvrABC 
In order to investigate the effects of adduct structure on the extent of strand opening 
required for damage recognition, synthetic duplex DNA substrates adducted with either AF or 
AAF were constructed.  Although the ring structures are very similar, they adopt distinctly 
different conformations in duplex DNA with AF residing primarily in the major groove while 
AAF intercalates into the duplex (139, 141-143, 146).  These substrates contained bubbles 
formed from nucleotide mismatches between the strands 3’ to the adducted nucleotide to mimic 
3’ strand opening generated by the UvrABC system during damage recognition.  Figure 5-1 
presents the results of in vitro incision using the UvrABC nuclease system. As the bubble size 
increases from zero to three mismatched nucleotides the incision efficiency increases for both 
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adducts (Figure 5-1, Panels A and B, Lanes 1-4).  These effects are most pronounced for the AF 
adduct (Figure 5-1A), however increasing the size of the helical distortion also increases incision 
of the AAF adducted DNA (Figure 5-1B).  Increasing the size of the bubble to six mismatched 




Figure 5-1:  UvrABC Incision Of AF And AAF Bubble Substrates 
32
P-labeled 50bp duplex DNA substrates containing either AF (panel A) or AAF (panel B) were 
incubated with UvrABC proteins and the substrates and products resolved on a 12% denaturing 
PAGE gel.  The presence of an 18-mer oligonucleotide indicates the dual incision by the UvrBC 
pre-incision complex.  Substrates containing a three-nucleotide mismatch displayed the most 




(Figure 5-1B, Lane 5).  These results suggest that although AF and AAF adducts adopt different 
conformations in duplex DNA the size of the strand opening required for identification of the 
adduct is the same.    Further increasing the size of the bubble to ten mismatched nucleotides 
surrounding the adducted nucleotide resulted in approximately equal incision of both substrates 
(Figure 5-1, Panels A and B, Lane 6); however, this most likely indicates non-specific incision 
by the UvrBC2 complex.   
 
Sequence Context Affects Recognition of DNA Helix Distortion 
In addition to bubble size, sequence context surrounding the damage site also was 
investigated.  Sequence-specific 50bp duplex substrates containing either AF or AAF adduct 
were subject to in vitro UvrABC incision as described above.  The substrates constructed 
contained a damaged nucleotide (G*) located in either a TG*T or CG*C sequence for both AF 
and AAF adducts.  Figure 5-2 illustrates the effects of sequence context on incision rates.  When 
the adducted nucleotide is located in a TG*T sequence the incision efficiency is approximately 
70% greater than when the damaged nucleotide is located in a CG*C sequence.  Table 5-1 
summarizes the quantification of UvrABC incision.  These results suggest the amount of  
 






Figure 5-2:  Effects Of DNA Sequence Context On UvrABC Incision Efficiency 
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32
P-labled 50bp duplex DNA substrates containing either a AAF (panel A) or AF (panel B) 
adducted guanine nucleotide contained in either TG*T or CG*C sequence where G* is the 
modified nucleotide.  Substrates were incubated with UvrABC proteins and resolved on a 12% 
denaturing gel.  The presence of an 18-mer oligonucleotide indicates incision of the adducted 
DNA.  TG*T substrates displayed greater incision efficiency than substrates in which the 
adducted nucleotide was located in CG*C sequence.   
 
hydrogen bonding surrounding the damaged nucleotide influence either the initial recognition or 
subsequent incision of the substrate.  In order to determine whether or not increased incision 
efficiency of the TG*T substrates was due to increased DNA damage recognition, 
electromobility shift assays (EMSA) were performed to determine the affinity of UvrA for the 
sequence-specific substrates containing AAF adducts.  The slower migrating bands observed 
correlate to the UvrA2-DNA complex.  Similar to the results obtained for the UvrABC incision 
assay, UvrA2 bound to the TG*T substrate with a higher affinity than was observed for the 
CG*C substrate.  The dissociation constant, Kd, for each of the AAF-adducted substrates were 
estimated at 12.5 nM and 8 nM for the CG*C and TG*T substrates, respectively.  These 
quantifications represent an approximate 50% greater affinity of UvrA for AAF adducts 
contained in the TG*T sequence over the CG*C sequence These results suggest that when the 
adduct is contained in G-C regions, the availability of additional hydrogen bonding between the 
strands reduces the amount of distortion in the substrate compared to when the adduct is 




Figure 5-3:  Effects Of DNA Sequence Context On UvrA2-DNA Complex Formation 
In order to evaluate the effects of DNA sequence on UvrA binding of the damaged DNA, 
electromobility shift assay was performed.  
32
P-labeled 50bp duplex DNA substrates were 
incubated with increasing amounts of UvrA protein and resolved by 3.5% native PAGE.  The 
slower migrating band represents the nucleoprotein complex while the faster migrating band 
represents the free substrate.  UvrA demonstrates an approximate 50% greater affinity for AAF 
adducts contained in a TG*T substrate compared to AAF adducts contained in a CG*C substrate. 
 
Confirmation that sequence context surrounding the adducted nucleotide influences the 
distortion of the helix, AAF-adducted TG*T and CG*C substrates were constructed in which the 
damage site was located in a three-nucleotide mismatch bubble.  Including the damage site in a 
bubble substrate should override any influence the initial helix distortion has on damage 
recognition and incision.  UvrABC incision and UvrA EMSA assays then were performed to 
examine the effects of sequence in context of helical distortion.  Figure 5-4A presents the results 
of UvrABC incision of TG*T and CG*C substrates containing AAF adducts in a three nucleotide 
bubble.  When the adducted nucleotide is contained in a three-nucleotide bubble, there is no 
significant difference in the UvrABC incision rates between the TG*T and CG*C substrates 
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(Figure 5-4A). In agreement with the incision data, inclusion of the damage site in a bubble 
structure negated the previously observed preference of UvrA for damages contained in the 
TG*T substrate compared to the CG*C substrate (Figure 5-4B).  These results support the 
hypothesis that sequence context increases DNA damage recognition by influencing the degree 
of helical distortion induced by the adduct. 
 
Sequence Context Influences Adduct Intercalation Into Duplex DNA 
In a related study, the effects of the adduct conformation on incision efficiency by the 
UvrABC nuclease system were investigated.  As described above, the amount of helical 
distortion induced by the adduct directly influences damage recognition by the UvrABC 
nuclease.  The effects of sequence identity on the equilibrium conformation of (2)-aminofluorene 
(AF) using its derivative, fluoro-(2)-aminofluorene (FAF), in duplex DNA was examined by 
NMR spectroscopy and subsequent incision by UvrABC.  FAF substrates contained an AF 
adduct modified with a “fluorine reporter probe” and were constructed for NMR analysis to 
determine the percent of damages intercalated into the helix (S-conformation) at equilibrium.  
However, it was unclear whether the fluorine probe would interfere with damage recognition and 
incision in in vitro NER assays.  Determination whether the FAF adduct could be substituted for 
the AF adduct, in vitro UvrABC incision assays were performed.  Figure 5-5A shows that there 
is no significant difference between incision rates for the FAF adducted substrates verses the AF 
adducted substrates.  Four substrates were tested, two containing FAF and two containing AF 
adducts in two independent sequences in order to verify FAF and AF are recognized and incised 
with the same efficiency. Once it had been established that FAF and AF adducts were 




Figure 5-4:  Effects Of DNA Sequence Context On Damage Recognition In Three-Nucleotide 
Mismatch Bubble Substrates 
32
P-labeled 50bp duplex DNA substrates containing AAF adducts in either TG*T or CG*C 
sequences were constructed with three nucleotide mismatches surrounding the damage site.  (A) 
Substrates were incubated with UvrABC and resolved by 12% denaturing PAGE.  Both TG*T 
and CG*C substrates were incised with similar efficiencies when contained in bubble structures.  
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(B) Substrates were incubated with UvrA and resolved by 3.5% native PAGE.  Similar to the 
incision data, both TG*T and CG*C substrates were recognized with similar efficiencies.   
a three nucleotide bubble there is no significant difference in the UvrABC incision rates between 
the TG*T and CG*C substrates. In agreement with the incision data, inclusion of the damage site 
in a bubble structure negated the previously observed preference of UvrA for damages contained 
in the TG*T substrate compared to the CG*C substrate.   
  
previously analyzed by NMR to determine the role of S-conformation on incision efficiency.  
NMR analysis of FAF-adducted 51 bp DNA duplex substrates indicated that the identity of the 
nucleotide immediately 3’ to the damaged residue influences the equilibrium conformation of the 
adduct.  Specifically, the percent of FAF adducts intercalated into the helix (S-conformation) 
increased as the identity of the 3’ neighboring nucleotide changed from TCAG (where T 
represented the least amount of S-conformation and G represented the highest amount).  When 
incision rate as determined by in vitro UvrABC incision assay was plotted against the percent S-
conformation for a specific substrate a nearly linear correlation between incision rate and 
conformation was observed (Figure 5-5B).  As the percent of DNA damage in the S-
conformation at equilibrium increased the incision rate also increased.  These data suggest the 
sequence context surrounding the adducted nucleotide directly influences the conformation the 
adduct adopts in the duplex which in turn influences the damage recognition efficiency of the 






Figure 5-5:  Effects Of Sequence Context On Adduct S-Conformation And Recognition By The 
UvrABC Nuclease 
(A) In vitro incision assays were performed to compare the incision rates of FAF to those of AF 
in order to verify the presence of the fluorine tag did not affect UvrABC incision.  (B) UvrABC 
incision rates for FAF 51bp substrates increased with a near linear correlation as the percent of 
DNA damages in the base-stacking conformation (S-conformation) increased.  Percent S-
conformation was determined by NMR spectroscopy and is reported as percent conformation at 










 The integrity of the genome is a paramount priority for all cells in order to ensure proper 
cellular function and survival of the species from one generation to the next.  To safeguard the 
genome, cells have evolved multiple pathways for the efficient detection and removal of DNA 
damage to prevent genome instability.  Among these pathways are the nucleotide excision repair 
pathway (NER) and the ATR-mediated DNA-damage checkpoint.  The NER pathway is 
responsible for the removal of a variety of bulky yet structurally unrelated lesions in DNA.  In 
addition, the ATR-mediated DNA-damage checkpoint is responsible for surveying the genome 
for signs of replication stress due to DNA damage induced by genotoxic chemicals and UV 
irradiation.  Together these two pathways serve to coordinate DNA damage repair and cell cycle 
progression to ensure complete and efficient repair of the genome to prevent mutation and 
genome instability.   
 At the heart of both DNA-damage response pathways is the formation of higher order 
DNA-protein and protein-protein complexes.  The formation of these complexes is pre-requisite 
for the recognition of DNA damage and the correct positioning of protein factors necessary for 
damage repair to occur.  Replication protein A (RPA) is a necessary protein factor required for 
DNA repair and ATR checkpoint pathway initiation as well as almost all DNA metabolisms 
generating ssDNA.  Although RPA is an extensively studied protein (reviewed in (37)) an 
understanding of how full-length RPA interacts structurally with ssDNA remains elusive.  
Currently there are several solution structures for various domains of RPA including the p70-
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DNA binding domains DBD-AB bound to a dT-8mer ssDNA substrate (39-41, 81, 82).  These 
structures, however, are limited only to independent domains of RPA and do not accurately 
describe how the intact protein binds to the full-length 30 nucleotide preferred substrate.   
 In the current study (Chapter 2) a lysine-specific chemical modification method coupled 
with mass spectrometry was used to map the surface topology of intact RPA protein in complex 
with dT-30mer ssDNA.  The efficacy of this method was verified by identifying two lysine 
residues in DBD-AB previously shown to contact ssDNA by co-crystallography (81).  In 
addition, three lysine residues (K489, K577, and K588) in the third DNA-binding domain, DBD-
C, were also identified.  This represents the first structural study of the entire RPA-ssDNA 
nucleoprotein complex with single-amino acid resolution.  The identification of multiple lysine 
residues in DBD-C also correlates well with the available biochemical data demonstrating a 
three-fold increase in the affinity of RPA for ssDNA as the length increases from 12 nt (bound 
by DBD-AB) to 20 nt (the length at which DBD-C engages the substrate) (62).  These 
observations indicate that this method not only is capable of resolving the structure of a 
nucleoprotein complex, such as that of RPA-ssDNA, but also has the ability to predict whether a 
domain or cluster of residues is critical for the complex formation. 
 Recent studies have demonstrated that the Ataxia-telangiectasia mutated and RAD3-
related (ATR)-dependent DNA damage response pathway may interact with the NER pathway 
(91).  Specifically, ATR was shown to directly bind to and phosphorylate the critical NER factor 
XPA at serine residue 196 located in the minimum DNA binding domain in an event that 
promoted cell survival post UV-C irradiation.  To further understand the relationship between the 
ATR checkpoint pathway and NER, we examined the effects of ATR on the sub-cellular 
distribution of XPA in response to UV-C irradiation (presented in Chapter 3).  We observed that 
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the majority of XPA in cells prior to UV-C irradiation is sequestered in the cytosol but undergoes 
rapid redistribution to the nucleus following irradiation.  Indeed, the redistribution of XPA 
occurred in both a dose-dependent and time-dependent manner.  Also, using either chemical 
inhibitors or siRNA technology to silence the ATR kinase we found that the nuclear 
accumulation of XPA was directed by the ATR-dependent checkpoint pathway.  However, when 
we compared the times at which nuclear accumulation and XPA phosphorylation occurred, we 
found the times did not correlate to each other.  In addition, only a small portion of cellular XPA 
undergoes phosphorylation upon UV-C-irradiation.  These results suggest that XPA 
phosphorylation is unlikely a factor required for the sub-cellular redistribution of the protein in 
response to UV-C irradiation.   
Directing nuclear import of XPA and phosphorylation of nuclear XPA protein represent 
two methods for the modulation of NER activity by the ATR-mediated DNA damage 
checkpoint.  As an immediate response to DNA damage ATR directs the nuclear import of XPA, 
a factor required for both the GGR and TCR sub-pathways, to promote initiation of NER and 
repair of lesions.  (6-4) photoproducts [(6-4)PPs] represent only ~25% of the damage generated 
by UV-C irradiation, but they are quickly removed by NER activity, typically within 2 hours 
(138).  We observed that inhibition of ATR activity either by chemical inhibitors or siRNA 
knockdown reduced the repair efficiency of (6-4)PPs relative to mock treatment.  The reduced 
repair efficiency of (6-4)PPs is most likely due to lower availability of XPA in the nucleus 
because of lack of ATR-dependent XPA nuclear import.   In addition to the immediate sub-
cellular redistribution of XPA, ATR-dependent phosphorylation of XPA provides a second, 
later-acting response to DNA damage.  UV-C irradiation results primarily in the formation of 
cyclobutane pyrimidine dimers (CPDs) (>75% of total lesions), and CPD lesions are repaired at a 
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much slower rate compared to the (6-4)PPs requiring over 24 hours to be cleared (138).  
Mutation of the S196 phosphorylation site on XPA to alanine resulted in increased sensitivity to 
UV-C irradiation compared to cells expressing wild-type protein (91).  Given that XPA 
phosphorylation reaches maximum levels at time points greater that four hours (91), it is possible 
this mechanism modulates repair of persistent DNA damages, such as CPDs. 
The study presented in Chapter 4 represents a continuation of the investigation of the 
ATR-XPA interaction described in Chapter 3.  This project centered on defining what regions or 
motifs in the XPA protein were required for complex formation with ATR.  Using the mass 
spectrometry footprinting technique described in Chapter 2 it was determined that an -helix 
located in the minimum DNA-binding domain of XPA was involved in complex formation 
between XPA and ATR.  This structure is the N-terminal helix of a helix-turn-helix motif that 
constitutes part of the proposed XPA DNA-binding cleft and contains the ATR phosphorylation 
site, S196.  A single surface lysine residue, K188, was protected from biotin modification 
following binding of XPA to ATR, and when K188 was mutated to an alanine residue, the ability 
of ATR and XPA to form a complex was abolished as determined by co-immunoprecipitation.  
However, mutation of K188 to glutamic acid resulted in no change in ATR-XPA complex 
formation.  This suggests that other residues on the helix may mediate the complex formation 
and that K188 may be necessary for stabilization of the -helix.  Our chemical modification was 
specific for lysine residues only and, therefore, the participation of additional residues in 
complex formation cannot be ruled out.   
The ability of phosphorylation-deficient XPA to support repair of cyclobutane pyrimidine 
dimers (CPDs) was examined.  In Chapter 3 it was described that when the ATR-dependent 
checkpoint pathway was abrogated repair efficiency of the UV-C-induced lesion (6-4)PP was 
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reduced suggesting two possible roles for ATR modulating NER activity (54).  However, given 
that XPA phosphorylation occurs at later time points post UV-C-irradiation (91), it suggests that 
nuclear import is primarily responsible for this phenotype.  Therefore, the role of 
phosphorylation on repair efficiency of the persistent UV-C-induced lesion CPD was 
investigated using XPA-deficient cell lines complemented with either wild type XPA or XPA 
lacking the  phosphorylation site (Serine196Alanine196).  Indeed, XPA-/- cells complemented 
with XPA-S196A phosphorylation-deficient protein had reduced repair efficiency for CPD 
lesions compared with cells complemented with wild-type protein.  These results suggest a two-
step mechanism for ATR-dependent modulation of NER activity through interaction with XPA 
to promote repair of lesions across time.   
The decreased repair efficiency of CPD lesions by phosphorylation-deficient XPA 
coupled with previous data demonstrating that phosphorylated XPA is more tightly chromatin-
associated (91) indicate that phosphorylation may modulate the affinity of XPA for the damage 
site.  While computational modeling of the effects of phosphorylation on the surface charge 
distribution of XPA minimum DNA-binding domain did not reveal any increase in positive 
charge in the proposed DNA-binding site, a significant increase in negative charge was observed 
on the helix-turn-helix motif.  This motif is in close proximity to both the RPA70 and TFIIH 
binding sites on XPA.  An increase in complex formation with either of these two protein factors 
could explain the higher affinity of phosphorylated XPA for damaged chromatin.     
Chapter 5 presents a summary of work published in two journal articles during the course 
of this dissertation.  These studies were designed to investigate the mechanisms of DNA damage 
recognition in the NER pathway.  Using the E. coli UvrABC nuclease system as a model of NER 
we determined the effects of different types of DNA damage on the structure of DNA strand 
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opening of the repair intermediates during NER.  The structural determinants of DNA damage 
for the second-step damage recognition were characterized as well as the effects of DNA 
sequence on the types of damage-induced helical distortions and the corresponding repair 
efficiencies.  The results show that the chemical identity of the adduct, not the amount of helical 
distortion induced, was the primary determinant for determining the size of the bubble generated 
by UvrA2B.  This was apparent as the optimum strand opening for both AF and AAF adducts 
was found to be three nucleotides even though they induced different amounts of helical 
distortion.  It is hypothesized that the size of the strand opening developed by UvrA2B is based 
on the size the lesion and the availability of UvrB to contact it.  Indeed, in additional sections of 
this paper, it was found that the chemical adduct benzo[]-pyrene diol epoxide (BDPE) required 
a six-nucleotide opening for efficient incision.  BPDE contains a much larger aromatic ring 
moiety than AF and AAF, indicating the size of the aromatic ring group dictates the size of the 
opening required for the second recognition step by UvrB.      
Finally, this work demonstrated that the sequence context surrounding the damage site 
influences the amount of helical distortion the adduct induces.  When both AF and AAF 
adducted nucleotides are flaked by thymine residues the distortion is more pronounced than 
when the adduct is flanked by cytosine residues.  This is most likely due to additional hydrogen 
bonding between C-G nucleotide pairs compared to T-A nucleotide pairs.  In a related study, our 
data showed that sequence context surrounding the damage site influenced the conformation 
equilibrium of the damaged nucleotide thereby affecting the rate of repair by UvrABC.  Using 
NMR spectroscopy to elucidate the conformation equilibrium of an FAF adduct proved that the 
surrounding sequence contributed to determining whether the adduct was stacked into the helix 
or was positioned in the major groove.  Stacking of the aromatic rings into the helix leads to 
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increased disruption of the hydrogen bonding between the two strands.  As the conformation 
equilibrium shifted to the stacked conformation, damage recognition and incision by the 
UvrABC nuclease system increased with a linear correlation.  These results demonstrate that the 
amount of hydrogen bonding between the two strands directly influences the recognition of DNA 
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(6-4)PP, (6-4) photoproduct 
9-1-1, Rad9-Rad1-Hus1 complex 
AF, (2)-aminofluorene 
AAF, N-acetyl-(2)-aminofluorene 
ATM, Ataxia telangiectasia mutated 
ATP, adenosine triphosphate 
ATR, Ataxia telangiectasia mutated and RAD3-related 
ATRIP, ATR interacting protein 
bp, base pair 
BPDE, benzo[]-pyrene diol epoxide 
CPD, cyclobutane pyrimidine dimer 
CPT, camptothecin 
DAPI, 4’,6-diamidino-2-phenylindole 
DBD, DNA binding domain 
DDB, damaged DNA binding protein 
DMEM, Dulbecco’s modified Eagle’s medium 
DNA, deoxyribonucleic acid 
Dox, doxycycline 
DSB, double strand break 
dsDNA, double-stranded DNA 
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EMSA, electromobility shift assay 
ERCC1, excision repair cross complementation group 1 
FAF, fluoro-(2)-aminofluorene 
FBS, fetal bovine serum 
GAPDH, glyceraldehyde-3-phosphate dehydrogenase 
GFP, green fluorescent protein 
GGR, global genome repair 
hRPA, human replication protein A 
HTH, helix-turn-helix 
kDa, kilodalton 
LC, liquid chromatography 
MALDI-TOF, matrix assisted laser desorption time of flight 
MS, mass spectrometry 
MS/MS, tandem mass spectrometry 
m/z, mass/charge ration 
NER, nucleotide excision repair 
NHS-biotin, N-hydroxysuccinimidobiotin 
NMR, nuclear magnetic resonance 
nt, nucleotide 
OB-fold, oligonucleotide/oligosaccharide binding fold 
PAGE, polyacrylamide gel electrophoresis 
PBS, phosphate buffered saline 
PDB, Protein Data Bank 
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PIKK, phosphatidylinsoitol 3-kinase-related kinase 
PNK, polynucleotide kinase 
PARP, poly ADP ribose polymerase 
PVDF, polyvinylidene difluoride 
Q-TOF, quadrupole time of flight 
RPA, replication protein A 
S-conformation, base-stacked conformation 
SDS-PAGE, sodium docecyl sulfate polyacrylamide gel electrophoresis 
siRNA, small interfering ribonucleic acid 
ssDNA, single-stranded DNA 
TBE, Tris-Borate-EDTA 
TCR, transcription coupled repair 
TFIIH, transcription factor II H 
UV, ultraviolet 
UV-C, ultraviolet C 
XP, Xeroderma pigmentosum 
XPA-G, Xeroderma pigmentosum complementation group A-G 
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